{"gene":"HSPD1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1989,"finding":"Mitochondrial Hsp60 is required for the folding of proteins imported into mitochondria; folding occurs at the surface of Hsp60 in an ATP-hydrolysis-dependent reaction followed by release of the bound polypeptide, establishing Hsp60 as an ATP-dependent protein-folding catalyst in the mitochondrial matrix.","method":"In vitro import and folding assays in isolated yeast mitochondria; biochemical reconstitution","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro folding assay with ATP-dependence, foundational paper with 576 citations","pmids":["2528694"],"is_preprint":false},{"year":1989,"finding":"The primary structure of human mitochondrial HSP60 (P1) shows 40–50% sequence identity to bacterial GroEL, the mycobacterial 65 kDa antigen, and the chloroplast rubisco-binding protein, establishing HSP60 as the mammalian chaperonin homolog and suggesting a conserved posttranslational assembly role.","method":"cDNA cloning and sequence analysis; amino acid sequence alignment","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — direct molecular characterization; 479 citations; establishes identity and homology of human HSPD1","pmids":["2568584"],"is_preprint":false},{"year":1990,"finding":"Hsp60 monomers require pre-existing functional Hsp60 14-mer complexes for their own assembly into new 14-mer rings after mitochondrial import; assembly of newly imported subunits occurs with a half-time of 5–10 min and is thus a catalysed (not spontaneous) reaction.","method":"In vitro import into isolated mitochondria from hsp60-defective yeast mutant mif4; pulse-chase assembly assays; biochemical fractionation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in defined mutant background with kinetic analysis; 169 citations","pmids":["1978929"],"is_preprint":false},{"year":1992,"finding":"Murine Hsp60 physically associates with p21ras in intact cells, as demonstrated by chemical cross-linking under conditions where mitochondrial Hsp60 release does not alter the amount complexed to p21ras, suggesting a physiological cytosolic interaction between Hsp60 and Ras.","method":"Chemical cross-linking followed by co-immunoprecipitation; cDNA cloning and partial amino acid sequencing to identify the 60 kDa binding partner","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 — single cross-linking/Co-IP experiment; moderate citation count","pmids":["1347942"],"is_preprint":false},{"year":1997,"finding":"GroEL/Hsp60-mediated folding operates through: (1) binding of nonnative polypeptides at hydrophobic apical-domain sites, (2) ATP-binding-triggered conformational changes that encapsulate the substrate with GroES/Hsp10 in a cis ternary complex, (3) folding inside the sequestered cavity, (4) ATP hydrolysis in the cis ring priming product release, and (5) ATP binding to the trans ring dismantling the cis complex—enabling iterative recycling of non-native substrates.","method":"Structural crystallography, cryo-EM, biochemical ATPase assays, mutational analysis — comprehensive mechanistic review synthesizing multiple experimental approaches","journal":"Protein science : a publication of the Protein Society","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods across many labs; >300 citations; replicated mechanism","pmids":["9098884"],"is_preprint":false},{"year":1998,"finding":"The GroEL-GroES complex undergoes major asymmetric conformational changes upon ATP binding: apical domain twisting removes hydrophobic substrate-binding sites from the cavity lining and creates a hydrophilic folding chamber; ATP hydrolysis is not needed for a single round of encapsulation but is required for trans-ring ATP binding to dismantle the cis complex and release substrate.","method":"X-ray crystallography of GroEL·GroES·(ADP)7 complex; cryo-EM of allosteric states; biochemical ATPase assays","journal":"Annual review of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus biochemical validation; replicated; 436 citations","pmids":["9759498"],"is_preprint":false},{"year":1999,"finding":"Pro-caspase-3 is present in mitochondria in a complex with Hsp60 and Hsp10; upon induction of apoptosis, pro-caspase-3 dissociates from the Hsps, which are released from mitochondria. Recombinant Hsp60 and Hsp10 accelerate activation of pro-caspase-3 by cytochrome c and dATP in an ATP-dependent manner in vitro.","method":"Co-immunoprecipitation from mitochondrial fractions; in vitro caspase activation assay with recombinant proteins; subcellular fractionation; Western blot","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal Co-IP plus reconstituted in vitro activation assay; 438 citations","pmids":["10205158"],"is_preprint":false},{"year":2004,"finding":"GroEL induces structural rearrangements in a nonnative RuBisCO intermediate: it first partially unfolds or expands the substrate upon capture, then spatially constricts it within the GroEL-GroES cavity, driving the substrate toward compact, folding-competent states. This two-step mechanism (expansion then compression) is ATP- and GroES-dependent.","method":"Fluorescence resonance energy transfer (FRET) between amino- and carboxy-terminal domains of RuBisCO; low-temperature trapping of monomeric non-aggregating intermediate; kinetic reactivation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — FRET with functional reactivation assay; mechanistic dissection with multiple controls","pmids":["15469819"],"is_preprint":false},{"year":2005,"finding":"Mortalin/mtHsp70 and HSP60 interact both in vivo and in vitro; the N-terminal region of mortalin mediates this interaction. Both proteins co-localize in mitochondria, and suppression of HSP60 expression causes cancer cell growth arrest similar to mortalin suppression.","method":"Co-immunoprecipitation in vivo and in vitro; shRNA-mediated knockdown; immunofluorescence co-localization","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2–3 — reciprocal Co-IP plus domain mapping and functional KD; single lab","pmids":["15957980"],"is_preprint":false},{"year":2007,"finding":"HSP60 is released from adult cardiac myocytes via the exosomal pathway; within exosomes, HSP60 is tightly attached to the exosomal membrane. The classic Golgi-mediated secretory pathway is not responsible for HSP60 release.","method":"Exosome isolation; electron microscopy; Western blot of exosomal fractions; pathway inhibitor studies ruling out classical secretion","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — direct fractionation and localization with functional pathway dissection; 299 citations","pmids":["17307989"],"is_preprint":false},{"year":2007,"finding":"Hsp60 maintains a mitochondrial pool of survivin (stabilizing it) and forms a complex with p53 that restrains p53 function; siRNA ablation of Hsp60 destabilizes mitochondrial survivin, disrupts the Hsp60-p53 complex causing p53 stabilization, increases pro-apoptotic Bax expression, and activates caspase-dependent apoptosis selectively in tumor cells.","method":"High-throughput proteomics screening; siRNA knockdown; Co-immunoprecipitation; mitochondrial fractionation; caspase activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — proteomics plus Co-IP plus functional siRNA with specific apoptotic readouts; 223 citations","pmids":["18086682"],"is_preprint":false},{"year":2009,"finding":"HSP60 interacts with β-catenin via its apical domain, increases β-catenin protein levels, and enhances β-catenin transcriptional activity to promote metastatic phenotypes in vitro and in vivo; siRNA-mediated repression of β-catenin reverts HSP60-induced metastasis, and this effect is independent of proteasomal activity.","method":"Co-immunoprecipitation; overexpression and siRNA knockdown; in vitro invasion assays; in vivo metastasis assays; domain mapping","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP with domain mapping plus loss- and gain-of-function; single lab; 101 citations","pmids":["19369584"],"is_preprint":false},{"year":2009,"finding":"HSP60 interacts with YB-1 at the YB-NLS region in the cytoplasm; this interaction regulates the polysome association and subcellular distribution of YB-1: knockdown of HSP60 increases polysome-associated YB-1, while HSP60 overexpression decreases YB-1 in heavy-sedimenting polysome fractions and suppresses YB-NLS nuclear translocation activity.","method":"Co-immunoprecipitation; sucrose gradient sedimentation; siRNA knockdown; overexpression; subcellular fractionation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP plus functional KD/OE with polysome fractionation; single lab","pmids":["19470374"],"is_preprint":false},{"year":2010,"finding":"Homozygous inactivation of the Hspd1 gene in mice causes early embryonic lethality shortly after implantation (E6.5–7.5), demonstrating that Hspd1 is an essential gene for mammalian embryonic development; heterozygous mice show reduced Hsp60 and Hsp10 protein levels but survive normally.","method":"Gene-trap mouse knockout; genotyping; quantitative RT-PCR; Western blot; embryo staging","journal":"Cell stress & chaperones","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined lethal phenotype and confirmed knockdown; 70 citations","pmids":["20393889"],"is_preprint":false},{"year":2013,"finding":"Extracellular HSP60 induces inflammatory cytokine production in cardiomyocytes via TLR4–MyD88–p38/NF-κB signaling, and upregulates TLR2/4 expression via TLR4–MyD88–JNK/NF-κB signaling. During ischemia, endogenous HSP60 released extracellularly triggers the same pathways to promote myocardial inflammation.","method":"Cytokine ELISA; TLR blocking antibodies; pathway inhibitors (p38, JNK, NF-κB); siRNA for MyD88/TLR4; rat LAD ligation model","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal pathway inhibition experiments with in vitro and in vivo confirmation; 97 citations","pmids":["23447644"],"is_preprint":false},{"year":2013,"finding":"Hsp60 interacts with manganese superoxide dismutase (MnSOD) and is required for proper MnSOD folding; in a heterozygous Hsp60-knockout mouse model, reduced Hsp60 availability leads to impaired MnSOD function and increased oxidative stress in neuronal tissues, identifying MnSOD as a substrate of the Hsp60 folding machinery.","method":"Co-immunoprecipitation; heterozygous knockout mouse model; ROS measurements; enzymatic activity assays for MnSOD","journal":"Free radical research","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus KO model with functional readout; single lab","pmids":["24151936"],"is_preprint":false},{"year":2014,"finding":"The GroEL-GroES2 'football' complex (symmetric, both rings capped) is the protein-folding functional form. Substrate protein-catalyzed ADP/ATP exchange enables both chambers to encapsulate substrate efficiently when substrate binding precedes ATP. The two rings of GroEL function as a parallel processing machine in this form, differing conformationally from the asymmetric 'bullet' complex at both the GroEL-GroES interface and the inter-ring interface.","method":"Cryo-EM structure determination (~3.7 Å); calibrated FRET; order-of-addition biochemical experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — near-atomic cryo-EM structure plus orthogonal biochemical validation","pmids":["25136110"],"is_preprint":false},{"year":2015,"finding":"FUS (ALS/FTLD-associated RNA-binding protein) interacts with HSP60 and uses this interaction to translocate to mitochondria; downregulating HSP60 reduces mitochondrially localized FUS and partially rescues mitochondrial defects and neurodegenerative phenotypes caused by FUS in transgenic Drosophila.","method":"Co-immunoprecipitation; biochemical fractionation; HSP60 siRNA knockdown; transgenic Drosophila genetics; mitochondrial morphology assays","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus genetic epistasis in Drosophila model; multiple orthogonal methods; 155 citations","pmids":["26335776"],"is_preprint":false},{"year":2015,"finding":"Gold(III) porphyrin (gold-1a) directly targets and inhibits Hsp60 chaperonin activity in vitro and in cells; inhibition of Hsp60 by gold-1a depends on both the gold(III) ion and the porphyrin ligand working together, as shown by structure-activity studies with non-porphyrin gold(III) complexes and other metalloporphyrins.","method":"Photo-affinity labeling; click chemistry; chemical proteomics; cellular thermal shift assay; saturation-transfer difference NMR; protein fluorescence quenching; protein chaperone refolding assay","journal":"Angewandte Chemie (International ed. in English)","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biophysical and biochemical methods confirming direct target engagement and functional inhibition","pmids":["26663758"],"is_preprint":false},{"year":2015,"finding":"Mitochondrial Lon protease associates with the Hsp60-mtHsp70 chaperone complex; Lon maintains protein stability/levels of the Hsp60-mtHsp70 complex under oxidative stress, and Lon's ability to inhibit apoptosis depends on Hsp60 binding to p53.","method":"Co-immunoprecipitation; shotgun mass spectrometry interactome; immunofluorescence co-localization; siRNA knockdown; apoptosis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2–3 — proteomics interactome confirmed by Co-IP plus functional dependency experiments; single lab","pmids":["25675302"],"is_preprint":false},{"year":2015,"finding":"Wild-type mammalian HSP60 forms heptameric single-ring structures in the absence of ATP, but forms predominantly football-type (symmetric double-ring) complexes with HSP10 in the presence of ATP. After ATP hydrolysis to ADP, HSP60 releases HSP10 and the double-ring dissociates to single rings, demonstrating an ATP-dependent single-ring ↔ double-ring transition distinct from the bacterial GroEL/GroES cycle.","method":"Purification from porcine liver; transmission electron microscopy; native PAGE; gel filtration; protein refolding assay","journal":"Archives of biochemistry and biophysics","confidence":"High","confidence_rationale":"Tier 1 — purified wild-type protein with structural (TEM) and biochemical validation; demonstrates key mechanistic difference from GroEL","pmids":["26427351"],"is_preprint":false},{"year":2017,"finding":"Myrtucommulone A (MC) directly binds HSP60 and inhibits its protein refolding activity; HSP60 inhibition by MC leads to aggregation of Lon protease-like protein (LONP) and leucine-rich PPR motif-containing protein (LRP130) in isolated mitochondria, identifying these as HSP60-dependent substrates.","method":"Protein fishing/affinity pulldown with MC as bait; protein refolding assay (malate dehydrogenase); 2D gel electrophoresis and MS identification of aggregated proteins in isolated mitochondria","journal":"Cell chemical biology","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro refolding assay plus substrate identification in organellar system; multiple orthogonal approaches","pmids":["28457707"],"is_preprint":false},{"year":2017,"finding":"HSP60 possesses GTPase activity in addition to its established ATPase activity; GTP alters HSP60 allostery, complex formation with HSP10, and protein folding activity differently than ATP, providing evidence for nucleotide-dependent functional modulation of the HSP60-HSP10 complex.","method":"GTPase activity assay; ATPase assay; native PAGE; protein folding reactivation assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 — direct enzymatic assay; single lab without independent replication","pmids":["29208924"],"is_preprint":false},{"year":2017,"finding":"miR-382 targets the 3′-UTR of HSPD1 mRNA, downregulating HSP60 protein expression; HSPD1 knockdown promotes oxidative stress by reducing thioredoxin (Trx) expression, while HSPD1 overexpression restores Trx levels and reverses TGF-β1-induced loss of E-cadherin, placing HSPD1 upstream of the Trx antioxidant pathway in renal fibrosis.","method":"miR-382 mimic/anti-miR; HSPD1 siRNA knockdown; HSPD1 overexpression; luciferase reporter (3′-UTR target validation); UUO mouse model; Western blot; redox markers","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 — validated miRNA target with gain- and loss-of-function and in vivo confirmation; single lab","pmids":["28680529"],"is_preprint":false},{"year":2018,"finding":"Mammalian HSP60 undergoes nucleotide-dependent assembly: HSP10 binding promotes HSP60 double-ring formation in the presence of ATP; after ATP hydrolysis to ADP, HSP10 is released and double-rings dissociate to single rings. This structural transition is highly distinctive from GroEL/GroES, particularly in complex formation mode and the roles of ATP binding versus hydrolysis.","method":"Multiple analytical techniques under near-physiological conditions: native MS, DLS, analytical ultracentrifugation, fluorescence; ATP/ADP titration experiments","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biophysical methods confirming nucleotide-dependent ring transitions under physiological conditions","pmids":["29415503"],"is_preprint":false},{"year":2018,"finding":"GroEL undergoes transient ring separation (ring exchange between complexes) upon ATP binding to the trans ring, driven by inter-ring negative allostery. A GroEL mutant unable to perform ring separation remains folding-active but populates symmetric GroEL:GroES2 football complexes where both rings function simultaneously rather than sequentially, leading to inefficient substrate binding/release and impaired E. coli growth.","method":"FRET-based ring exchange assay; GroEL ring-separation mutant; in vivo E. coli growth complementation; native gel electrophoresis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — engineered mutant with defined biochemical and in vivo phenotype; mechanistically rigorous","pmids":["29336887"],"is_preprint":false},{"year":2018,"finding":"Simple encapsulation of maltose binding protein (MBP) within the GroEL/ES cavity repairs a defined folding defect (V9G mutation that disrupts a preintermediate hydrophobic cluster) and restores wild-type folding rates, with or without ATP-driven cycling. This reveals a folding mechanism based on nonspecific equilibrium compression/confinement within the cavity rather than unfolding of misfolded intermediates.","method":"Hydrogen exchange-mass spectrometry (HX-MS); fluorescence refolding kinetics; site-directed mutagenesis; comparison of free-solution vs. cavity-encapsulated folding","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — HX-MS with mutagenesis defining the structural mechanism; orthogonal validation","pmids":["29295923"],"is_preprint":false},{"year":2019,"finding":"HSP60-survivin complexes exist in both cytosolic and mitochondrial compartments in a cell-type-dependent manner. In mitochondria, HSP60 promotes survival by stabilizing survivin and interacting with CCAR2 and p53. When HSP60 is released from mitochondria to cytosol upon death stimuli, it can promote apoptosis by stabilizing Bax, enhancing pro-caspase-3 activation, or increasing protein ubiquitination.","method":"Subcellular fractionation; Co-immunoprecipitation; siRNA knockdown; apoptosis assays; literature synthesis with mechanistic framework","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP and fractionation data combined with review synthesis; mechanistic conclusions partly inferential","pmids":["31861751"],"is_preprint":false},{"year":2020,"finding":"Cryo-EM structure of human mitochondrial HSPD1 in the apo state reveals that, unlike bacterial GroEL (which exists as double rings), HSPD1 forms mostly single-ring assemblies in the absence of co-chaperonin HSPE1. Comparison with GroEL shows a rotation and increased flexibility of the apical domain in HSPD1.","method":"Cryo-electron microscopy; 3D reconstruction and comparison with GroEL structures","journal":"iScience","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure revealing key structural distinction from prokaryotic homolog","pmids":["33506187"],"is_preprint":false},{"year":2020,"finding":"Disease-associated point mutations in HSPD1 (D29G and V98I linked to hereditary spastic paraplegia/hypomyelinating leukodystrophy) act primarily by destabilizing the oligomeric stability of the mtHsp60 complex rather than globally unfolding the monomer, suggesting oligomeric integrity is essential for folding function and neuronal survival.","method":"Biophysical characterization of purified mutant proteins; native gel electrophoresis; thermal stability assays; structural modeling; literature synthesis","journal":"Frontiers in molecular biosciences","confidence":"Medium","confidence_rationale":"Tier 2–3 — biochemical characterization of disease mutants; single lab; 21 citations","pmids":["32766281"],"is_preprint":false},{"year":2021,"finding":"HSPD1 knockdown or chemical disruption by small molecule KHS101 induces a drastic breakdown of oxidative phosphorylation (OXPHOS) and suppresses NSCLC proliferation in vitro and in vivo. A genome-wide CRISPR/Cas9 screen validated that KHS101 anti-cancer effects are dependent on OXPHOS, with SLC6A8 (creatine transporter) and COX5B (cytochrome c oxidase subunit) as determinants of sensitivity.","method":"HSPD1 CRISPR/Cas9 knockout; siRNA knockdown; KHS101 pharmacological inhibition; extracellular metabolic flux analysis (Seahorse); genome-wide CRISPR/Cas9 drug sensitivity screen; in vivo xenograft","journal":"Journal of experimental & clinical cancer research : CR","confidence":"High","confidence_rationale":"Tier 1–2 — genetic KO plus pharmacological inhibition plus CRISPR screen plus metabolic phenotyping; multiple orthogonal approaches","pmids":["34364401"],"is_preprint":false},{"year":2021,"finding":"Arsenic trioxide (ATO) binds directly to Hsp60 and abolishes its protein refolding capability; ATO binding disrupts the Hsp60-p53 and Hsp60-survivin complexes, resulting in degradation of both p53 and survivin in APL cells.","method":"Organoarsenic chemical probe metalloproteomics; quantitative proteomics; cellular thermal shift assay; biophysical binding assays; cell-based p53/survivin stability assays; protein refolding assay","journal":"Chemical science","confidence":"High","confidence_rationale":"Tier 1 — direct target identification with multiple biophysical methods plus functional consequence in cells","pmids":["34476069"],"is_preprint":false},{"year":2022,"finding":"GroEL-ES accelerates protein folding by strengthening polypeptide chain collapse: GroEL induces contractile forces in substrate chains drawing them into the cavity and triggering compaction and discrete folding transitions. Collapse enhancement is strongest in nucleotide-bound states, aided by GroES at the cavity rim and amphiphilic C-terminal tails at the cavity bottom. This mechanism is distinct from steric confinement and misfold-unfolding mechanisms.","method":"Integrated optical tweezers protein manipulation; single-molecule fluorescence imaging; nucleotide state-specific measurements; GroES binding assays","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — single-molecule manipulation with direct force measurement; mechanistic dissection of distinct folding contributions","pmids":["35245117"],"is_preprint":false},{"year":2008,"finding":"Patient cells heterozygous for the c.292G>A HSPD1 allele encoding Hsp60-p.Val98Ile show decreased expression of mitochondrial proteases Lon and ClpP at both RNA and protein levels, suggesting a compensatory cellular adaptation to reduced Hsp60 chaperonin activity that allows substrate proteins more folding attempts before degradation.","method":"qRT-PCR; Western blot; mitochondrial membrane potential; oxidative stress assays in lymphoblastoid and fibroblast cell lines from SPG13 patient","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2–3 — patient-derived cells with multiple molecular readouts; single patient/lab","pmids":["18378094"],"is_preprint":false},{"year":2005,"finding":"Cytosolic HSP60 in cardiac cells forms complexes with Bax, Bak, and Bcl-XL (but not Bcl-2) under normal conditions; during hypoxia, HSP60 redistributes from cytosol to the plasma membrane, coinciding with cytochrome c release from mitochondria prior to reoxygenation. Reduction in HSP60 expression precipitates apoptosis without altering mitochondrial function. Additionally, HSP60 accelerates cleavage of pro-caspase-3.","method":"Co-immunoprecipitation; subcellular fractionation; siRNA knockdown; hypoxia-reoxygenation model; immunofluorescence","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus fractionation plus functional KD; 145 citations; single lab","pmids":["15784164"],"is_preprint":false}],"current_model":"HSPD1 (mitochondrial HSP60) is an ATP-dependent Group I chaperonin that forms heptameric single rings (apo state) or football-type double rings with co-chaperonin HSPE1/Hsp10 in the presence of ATP; it binds non-native polypeptides at hydrophobic apical-domain sites, encapsulates them in a hydrophilic folding cavity upon ATP-driven conformational changes, promotes folding through cavity confinement and chain-collapse enhancement, and releases substrates after ATP hydrolysis and inter-ring allosteric signaling. Beyond canonical mitochondrial protein folding (including substrates such as MnSOD, LONP, and LRP130), HSP60 has established extra-mitochondrial roles: it forms complexes with survivin, p53, Bax/Bak/Bcl-XL, pro-caspase-3, mortalin/mtHsp70, β-catenin, and YB-1 to regulate apoptosis and cell survival; it is secreted via exosomes and signals extracellularly through TLR4–MyD88–NF-κB pathways to drive inflammation; and loss-of-function mutations (e.g., V98I, D29G) that destabilize the oligomeric complex cause hereditary spastic paraplegia (SPG13) and hypomyelinating leukodystrophy, while complete HSPD1 knockout is embryonic lethal in mice."},"narrative":{"teleology":[{"year":1989,"claim":"The foundational question of whether mitochondrial protein folding requires a dedicated catalyst was answered: HSP60 mediates ATP-dependent folding of imported mitochondrial proteins, establishing it as the first defined intracellular chaperonin.","evidence":"In vitro import and folding assays in isolated yeast mitochondria plus cDNA cloning confirming mammalian homology to GroEL","pmids":["2528694","2568584"],"confidence":"High","gaps":["Substrate range of mitochondrial HSP60 undefined","Mechanism of ATP coupling to folding unknown","Co-chaperonin requirement not yet addressed"]},{"year":1990,"claim":"Whether HSP60 oligomer assembly is spontaneous or assisted was resolved: newly imported HSP60 monomers require pre-existing functional 14-mer complexes for their own assembly, revealing a self-templating oligomerization mechanism.","evidence":"Import into mitochondria from hsp60-defective yeast mutant mif4 with pulse-chase assembly kinetics","pmids":["1978929"],"confidence":"High","gaps":["Structural basis of assisted assembly unknown","Stoichiometric requirements for template not defined"]},{"year":1997,"claim":"The complete chaperonin reaction cycle was delineated: substrate capture at hydrophobic apical sites, ATP-driven encapsulation with HSP10/GroES forming a cis ternary complex, folding in the sealed cavity, ATP hydrolysis priming release, and trans-ring ATP binding dismantling the complex for iterative recycling.","evidence":"Crystallography, cryo-EM, ATPase assays, and mutational analysis across multiple laboratories synthesized into a unified mechanism","pmids":["9098884","9759498"],"confidence":"High","gaps":["How the cavity environment actively promotes folding (beyond passive confinement) was unresolved","Mammalian-specific differences from GroEL not yet characterized"]},{"year":1999,"claim":"HSP60's role was extended beyond canonical folding to apoptosis regulation: HSP60 and HSP10 form a mitochondrial complex with pro-caspase-3 and accelerate its activation by cytochrome c in vitro, establishing HSP60 as a direct participant in caspase-dependent cell death.","evidence":"Co-immunoprecipitation from mitochondrial fractions and reconstituted in vitro caspase activation assay","pmids":["10205158"],"confidence":"High","gaps":["Whether HSP60 promotes or inhibits apoptosis appeared context-dependent and unresolved","Mechanism of HSP60 release from mitochondria unknown"]},{"year":2005,"claim":"The scope of HSP60's anti-apoptotic partnerships was broadened: cytosolic HSP60 complexes with Bax, Bak, and Bcl-XL in cardiac cells, and mitochondrial HSP60 interacts with mortalin/mtHsp70, with knockdown of either protein arresting cancer cell growth.","evidence":"Co-immunoprecipitation, subcellular fractionation, siRNA knockdown in cardiac and cancer cell lines","pmids":["15784164","15957980"],"confidence":"Medium","gaps":["Direct vs. indirect nature of Bax/Bak binding not resolved","Functional consequence of mortalin–HSP60 interaction on specific substrates unclear","Whether HSP60 chaperone activity is required for these interactions not tested"]},{"year":2007,"claim":"Two outstanding questions were answered: how HSP60 reaches the extracellular space and what it does there. HSP60 is released via exosomes from cardiac myocytes, and separately, HSP60 stabilizes mitochondrial survivin and restrains p53, with siRNA depletion activating caspase-dependent apoptosis in tumor cells.","evidence":"Exosome isolation with EM and pathway inhibitor studies; proteomics screening with Co-IP and siRNA knockdown","pmids":["17307989","18086682"],"confidence":"High","gaps":["Signals triggering exosomal HSP60 loading unknown","Whether HSP60–p53 interaction is direct or chaperoning-dependent not distinguished"]},{"year":2008,"claim":"Patient-derived cells carrying the SPG13-associated V98I mutation revealed a compensatory cellular adaptation: reduced HSP60 function led to decreased Lon and ClpP protease expression, suggesting cells modulate quality-control protease levels in response to impaired chaperoning.","evidence":"qRT-PCR and Western blot in lymphoblastoid and fibroblast lines from an SPG13 patient heterozygous for HSPD1 c.292G>A","pmids":["18378094"],"confidence":"Medium","gaps":["Single patient study limits generalizability","Causality between reduced HSP60 and protease downregulation not formally established","Whether this compensation is neuroprotective or pathological unknown"]},{"year":2010,"claim":"The question of whether HSP60 is essential in mammals was definitively answered: homozygous Hspd1 knockout causes embryonic lethality at E6.5–7.5 in mice, while heterozygotes survive with reduced HSP60/HSP10 levels.","evidence":"Gene-trap knockout mouse with genotyping, qRT-PCR, and Western blot","pmids":["20393889"],"confidence":"High","gaps":["Which specific mitochondrial substrates fail to fold and cause lethality unknown","Whether extra-mitochondrial HSP60 functions contribute to the lethal phenotype not tested"]},{"year":2013,"claim":"Extracellular HSP60 was shown to function as a danger-associated molecular pattern (DAMP): it drives inflammatory cytokine production via TLR4–MyD88–p38/NF-κB signaling in cardiomyocytes, and MnSOD was identified as a specific mitochondrial folding substrate whose impairment under HSP60 haploinsufficiency increases neuronal oxidative stress.","evidence":"TLR blocking antibodies and pathway inhibitors with in vivo LAD ligation; Co-IP and enzymatic activity assays in heterozygous knockout mouse","pmids":["23447644","24151936"],"confidence":"High","gaps":["Structural basis of HSP60–TLR4 recognition not determined","Whether MnSOD misfolding is the primary driver of neurodegeneration in SPG13 not established"]},{"year":2015,"claim":"A key structural distinction of mammalian HSP60 from bacterial GroEL was established: wild-type HSP60 exists as single heptameric rings in the apo state and transitions to double-ring football complexes with HSP10 only upon ATP binding, with ATP hydrolysis driving dissociation back to single rings.","evidence":"TEM, native PAGE, and gel filtration of purified porcine HSP60; complemented by native MS, DLS, and analytical ultracentrifugation","pmids":["26427351","29415503"],"confidence":"High","gaps":["Whether single-ring forms have independent folding activity unknown","Physiological triggers controlling the single-to-double ring transition in vivo not identified"]},{"year":2017,"claim":"Chemical biology approaches identified specific mitochondrial folding substrates: HSP60 inhibition by myrtucommulone A caused aggregation of LONP and LRP130, directly demonstrating their dependence on HSP60 for proper folding.","evidence":"Affinity pulldown with chemical probe; malate dehydrogenase refolding assay; 2D gel electrophoresis with MS identification of aggregated proteins in isolated mitochondria","pmids":["28457707"],"confidence":"High","gaps":["Complete substrate repertoire of mammalian HSP60 remains undefined","Whether substrate selectivity differs between single-ring and double-ring forms unknown"]},{"year":2018,"claim":"The physical mechanism by which the chaperonin cavity promotes folding was refined: encapsulation alone (without iterative cycling) repairs defined folding defects through equilibrium confinement-driven chain compaction, and GroEL rings undergo transient separation driven by inter-ring negative allostery that is required for efficient substrate processing in vivo.","evidence":"HX-MS of cavity-encapsulated MBP mutant; FRET-based ring exchange assays with engineered GroEL mutant plus in vivo growth complementation","pmids":["29295923","29336887"],"confidence":"High","gaps":["Whether mammalian HSP60 single-ring forms undergo analogous ring dynamics unknown","Extent to which confinement versus active unfolding contributes under physiological substrate loads not quantified"]},{"year":2020,"claim":"Disease mechanism was clarified at the structural level: cryo-EM of apo human HSP60 confirmed single-ring architecture with increased apical-domain flexibility relative to GroEL, and SPG13/leukodystrophy mutations D29G and V98I were shown to destabilize oligomeric integrity rather than monomer folding.","evidence":"Cryo-EM 3D reconstruction of human HSP60; biophysical characterization of purified mutant proteins with native gel and thermal stability assays","pmids":["33506187","32766281"],"confidence":"High","gaps":["Atomic-resolution structure of human HSP60–HSP10–ATP football complex not yet determined","How oligomeric destabilization specifically affects neuronal vulnerability in SPG13 not mechanistically explained"]},{"year":2021,"claim":"HSP60's essentiality for mitochondrial oxidative phosphorylation and its druggability were demonstrated: HSPD1 knockout or pharmacological inhibition collapses OXPHOS and suppresses cancer cell proliferation, and arsenic trioxide directly binds HSP60, abolishing refolding activity and disrupting HSP60–p53 and HSP60–survivin complexes.","evidence":"CRISPR knockout plus KHS101 inhibition with Seahorse metabolic profiling and genome-wide CRISPR drug-sensitivity screen; organoarsenic chemical proteomics with cellular thermal shift assay","pmids":["34364401","34476069"],"confidence":"High","gaps":["Therapeutic window for HSP60 inhibition in cancer versus toxicity to normal tissues not defined","Which OXPHOS complex subunits are direct HSP60 folding clients not identified"]},{"year":2022,"claim":"Single-molecule experiments revealed that GroEL/ES accelerates folding by actively strengthening polypeptide chain collapse via contractile forces drawing substrates into the cavity, a mechanism distinct from both passive steric confinement and iterative unfolding models.","evidence":"Integrated optical tweezers with single-molecule fluorescence imaging across defined nucleotide states","pmids":["35245117"],"confidence":"High","gaps":["Whether mammalian HSP60 exerts equivalent contractile forces on substrates not tested","Structural basis of force generation at the apical domain not resolved"]},{"year":null,"claim":"Major open questions remain: the complete substrate repertoire of mammalian HSP60 in vivo, the atomic-resolution structure of the human HSP60–HSP10–ATP complex, the mechanistic basis of tissue-specific vulnerability (particularly neuronal) to HSP60 deficiency, and whether the single-ring-to-double-ring transition is regulated by signals beyond ATP availability.","evidence":"","pmids":[],"confidence":"High","gaps":["No comprehensive substrate catalog for mammalian HSP60 exists","High-resolution human HSP60–HSP10–substrate ternary complex structure not determined","Cell-type-specific regulation of HSP60 ring dynamics not characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,4,5,7,26,32]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,4,5,20,24]},{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[22]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2,6,8,10,15,28]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,11,27,34]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[9,14]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[9]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[34]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,4,7,21,26,32]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,10,27,34]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[14]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[15,23]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[29,33]}],"complexes":["HSP60–HSP10 chaperonin complex","HSP60–mortalin/mtHsp70 complex","HSP60–survivin–p53 mitochondrial complex"],"partners":["HSPE1","HSPA9","TP53","BIRC5","CASP3","BAX","CTNNB1","YBX1"],"other_free_text":[]},"mechanistic_narrative":"HSPD1 encodes the mitochondrial 60 kDa chaperonin (HSP60), an ATP-dependent Group I chaperonin essential for folding proteins imported into the mitochondrial matrix and for maintaining mitochondrial proteostasis, with additional extra-mitochondrial roles in apoptosis regulation and innate immune signaling. HSP60 binds non-native polypeptides at hydrophobic apical-domain sites, undergoes ATP-driven conformational changes to encapsulate substrates with co-chaperonin HSPE1/HSP10 in a hydrophilic folding cavity, and promotes folding through chain-collapse enhancement and cavity confinement before releasing substrates upon ATP hydrolysis; unlike bacterial GroEL, mammalian HSP60 exists as single heptameric rings in the apo state and assembles into symmetric double-ring \"football\" complexes only upon ATP binding and HSP10 association [PMID:2528694, PMID:26427351, PMID:29295923, PMID:35245117]. Outside the mitochondrial matrix, HSP60 forms complexes with survivin, p53, and Bax/Bak to regulate apoptosis in a compartment-dependent manner—stabilizing survivin and restraining p53 in mitochondria while promoting caspase-3 activation upon cytosolic release—and is secreted via exosomes to activate TLR4–MyD88–NF-κB inflammatory signaling [PMID:10205158, PMID:18086682, PMID:17307989, PMID:23447644]. Loss-of-function mutations (D29G, V98I) that destabilize HSP60 oligomeric integrity cause hereditary spastic paraplegia (SPG13) and hypomyelinating leukodystrophy, and homozygous knockout is embryonic lethal in mice [PMID:32766281, PMID:20393889]."},"prefetch_data":{"uniprot":{"accession":"P10809","full_name":"60 kDa heat shock protein, mitochondrial","aliases":["60 kDa chaperonin","Chaperonin 60","CPN60","Heat shock protein 60","HSP-60","Hsp60","Heat shock protein family D member 1","HuCHA60","Mitochondrial matrix protein P1","P60 lymphocyte protein"],"length_aa":573,"mass_kda":61.1,"function":"Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:11422376, PubMed:1346131). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable)","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/P10809/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/HSPD1","classification":"Common Essential","n_dependent_lines":1207,"n_total_lines":1208,"dependency_fraction":0.9991721854304636},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MYH9","stoichiometry":4.0},{"gene":"AKAP8L","stoichiometry":0.2},{"gene":"ASS1","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"HDAC2","stoichiometry":0.2},{"gene":"INPP5K","stoichiometry":0.2},{"gene":"PHGDH","stoichiometry":0.2},{"gene":"PIP4K2C","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HSPD1","total_profiled":1310},"omim":[{"mim_id":"620258","title":"TRANSMEMBRANE PROTEIN 160; TMEM160","url":"https://www.omim.org/entry/620258"},{"mim_id":"615256","title":"ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT LYSINE METHYLTRANSFERASE; ETFBKMT","url":"https://www.omim.org/entry/615256"},{"mim_id":"615215","title":"POTASSIUM CHANNEL, SUBFAMILY U, MEMBER 1; KCNU1","url":"https://www.omim.org/entry/615215"},{"mim_id":"612233","title":"LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4","url":"https://www.omim.org/entry/612233"},{"mim_id":"612203","title":"NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 5; NAP1L5","url":"https://www.omim.org/entry/612203"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"adrenal gland","ntpm":696.8}],"url":"https://www.proteinatlas.org/search/HSPD1"},"hgnc":{"alias_symbol":["GroEL","HSP60"],"prev_symbol":["SPG13"]},"alphafold":{"accession":"P10809","domains":[{"cath_id":"1.10.560.10","chopping":"27-159_438-547","consensus_level":"medium","plddt":94.8594,"start":27,"end":547},{"cath_id":"3.30.260.10","chopping":"170-214_400-434","consensus_level":"high","plddt":88.9966,"start":170,"end":434},{"cath_id":"3.50.7.10","chopping":"217-362","consensus_level":"high","plddt":91.1936,"start":217,"end":362}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10809","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10809-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10809-F1-predicted_aligned_error_v6.png","plddt_mean":88.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HSPD1","jax_strain_url":"https://www.jax.org/strain/search?query=HSPD1"},"sequence":{"accession":"P10809","fasta_url":"https://rest.uniprot.org/uniprotkb/P10809.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10809/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10809"}},"corpus_meta":[{"pmid":"2528694","id":"PMC_2528694","title":"Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2528694","citation_count":576,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9759498","id":"PMC_9759498","title":"Structure and function in GroEL-mediated protein folding.","date":"1998","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9759498","citation_count":436,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9098884","id":"PMC_9098884","title":"GroEL-mediated protein folding.","date":"1997","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/9098884","citation_count":313,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17307989","id":"PMC_17307989","title":"HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway.","date":"2007","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17307989","citation_count":299,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7752884","id":"PMC_7752884","title":"Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of proteins and the origin of eukaryotic cells.","date":"1995","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/7752884","citation_count":230,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18086682","id":"PMC_18086682","title":"Hsp60 regulation of tumor cell apoptosis.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18086682","citation_count":223,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11160803","id":"PMC_11160803","title":"GroEL (Hsp60) of Clostridium difficile is involved in cell adherence.","date":"2001","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11160803","citation_count":174,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1978929","id":"PMC_1978929","title":"The mitochondrial chaperonin hsp60 is required for its own assembly.","date":"1990","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1978929","citation_count":169,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8466626","id":"PMC_8466626","title":"Sequence homologies between hsp60 and autoantigens.","date":"1993","source":"Immunology today","url":"https://pubmed.ncbi.nlm.nih.gov/8466626","citation_count":163,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26335776","id":"PMC_26335776","title":"FUS Interacts with HSP60 to Promote Mitochondrial Damage.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26335776","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15784164","id":"PMC_15784164","title":"HSP60, Bax, apoptosis and the heart.","date":"2005","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15784164","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23183375","id":"PMC_23183375","title":"Structure and allostery of the chaperonin GroEL.","date":"2012","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23183375","citation_count":141,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12507429","id":"PMC_12507429","title":"Directed evolution of substrate-optimized GroEL/S chaperonins.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12507429","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32582761","id":"PMC_32582761","title":"Hsp60 Post-translational Modifications: Functional and Pathological Consequences.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/32582761","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19369584","id":"PMC_19369584","title":"Interaction between HSP60 and beta-catenin promotes metastasis.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19369584","citation_count":101,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23447644","id":"PMC_23447644","title":"Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23447644","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8577709","id":"PMC_8577709","title":"A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8577709","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26663758","id":"PMC_26663758","title":"Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.","date":"2015","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/26663758","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29732373","id":"PMC_29732373","title":"Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics.","date":"2018","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/29732373","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15957980","id":"PMC_15957980","title":"Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15957980","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15469819","id":"PMC_15469819","title":"Expansion and compression of a protein folding intermediate by GroEL.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15469819","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33348708","id":"PMC_33348708","title":"Understanding GroEL and DnaK Stress Response Proteins as Antigens for Bacterial Diseases.","date":"2020","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/33348708","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25675302","id":"PMC_25675302","title":"Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25675302","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19127371","id":"PMC_19127371","title":"Conserved inserts in the Hsp60 (GroEL) and Hsp70 (DnaK) proteins are essential for cellular growth.","date":"2009","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/19127371","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20393889","id":"PMC_20393889","title":"Inactivation of the hereditary spastic paraplegia-associated Hspd1 gene encoding the Hsp60 chaperone results in early embryonic lethality in mice.","date":"2010","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/20393889","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18378094","id":"PMC_18378094","title":"Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13).","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18378094","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17164250","id":"PMC_17164250","title":"Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17164250","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14583338","id":"PMC_14583338","title":"Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury.","date":"2003","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14583338","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25136110","id":"PMC_25136110","title":"Formation and structures of GroEL:GroES2 chaperonin footballs, the protein-folding functional form.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25136110","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1354834","id":"PMC_1354834","title":"Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groES.","date":"1992","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/1354834","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31861751","id":"PMC_31861751","title":"Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31861751","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1347942","id":"PMC_1347942","title":"An interaction between p21ras and heat shock protein hsp60, a chaperonin.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1347942","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7961395","id":"PMC_7961395","title":"Subcellular localization and chaperone activities of Borrelia burgdorferi Hsp60 and Hsp70.","date":"1994","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7961395","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38791521","id":"PMC_38791521","title":"Molecular Chaperonin HSP60: Current Understanding and Future Prospects.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38791521","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28604836","id":"PMC_28604836","title":"Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28604836","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1680848","id":"PMC_1680848","title":"Involvement of GroEL in nif gene regulation and nitrogenase assembly.","date":"1991","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1680848","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9519301","id":"PMC_9519301","title":"Structural aspects of GroEL function.","date":"1998","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/9519301","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35609646","id":"PMC_35609646","title":"The multiple roles and therapeutic potential of HSP60 in cancer.","date":"2022","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35609646","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24460534","id":"PMC_24460534","title":"Versatile roles of the chaperonin GroEL in microorganism-insect interactions.","date":"2014","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24460534","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28457707","id":"PMC_28457707","title":"Mitochondrial Chaperonin HSP60 Is the Apoptosis-Related Target for Myrtucommulone.","date":"2017","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/28457707","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2575559","id":"PMC_2575559","title":"Cloning and characterization of the yeast chaperonin HSP60 gene.","date":"1989","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/2575559","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24151936","id":"PMC_24151936","title":"The Hsp60 folding machinery is crucial for manganese superoxide dismutase folding and function.","date":"2013","source":"Free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/24151936","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27478851","id":"PMC_27478851","title":"Does Hsp60 Provide a Link between Mitochondrial Stress and Inflammation in Diabetes Mellitus?","date":"2016","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/27478851","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11710845","id":"PMC_11710845","title":"Analysis of expression of GroEL (Hsp60) of Clostridium difficile in response to stress.","date":"2001","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11710845","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27630992","id":"PMC_27630992","title":"Disease-Associated Mutations in the HSPD1 Gene Encoding the Large Subunit of the Mitochondrial HSP60/HSP10 Chaperonin Complex.","date":"2016","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/27630992","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33782752","id":"PMC_33782752","title":"Lactobacillus stress protein GroEL prevents colonic inflammation.","date":"2021","source":"Journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33782752","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29336887","id":"PMC_29336887","title":"GroEL Ring Separation and Exchange in the Chaperonin Reaction.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29336887","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1567788","id":"PMC_1567788","title":"Induction of human hsp60 expression in monocytic cell lines.","date":"1992","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1567788","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15214052","id":"PMC_15214052","title":"HSP60 induces self-tolerance to repeated HSP60 stimulation and cross-tolerance to other pro-inflammatory stimuli.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15214052","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19207617","id":"PMC_19207617","title":"Localization of Hsp60 and Grp78 in the human testis, epididymis and mature spermatozoa.","date":"2009","source":"International journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/19207617","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17420924","id":"PMC_17420924","title":"A novel mutation in the HSPD1 gene in a patient with hereditary spastic paraplegia.","date":"2007","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17420924","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11427437","id":"PMC_11427437","title":"groEL encodes a highly antigenic protein in Burkholderia pseudomallei.","date":"2001","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11427437","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9427006","id":"PMC_9427006","title":"Structural and mechanistic consequences of polypeptide binding by GroEL.","date":"1997","source":"Folding & design","url":"https://pubmed.ncbi.nlm.nih.gov/9427006","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28586011","id":"PMC_28586011","title":"Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28586011","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19484809","id":"PMC_19484809","title":"Immunogenicity and protective efficacy of GroEL (hsp60) of Streptococcus pneumoniae against lethal infection in mice.","date":"2009","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19484809","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34364401","id":"PMC_34364401","title":"Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34364401","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22177460","id":"PMC_22177460","title":"What distinguishes GroEL substrates from other Escherichia coli proteins?","date":"2012","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/22177460","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34476069","id":"PMC_34476069","title":"Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin.","date":"2021","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/34476069","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15240489","id":"PMC_15240489","title":"The unfolding action of GroEL on a protein substrate.","date":"2004","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15240489","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12843026","id":"PMC_12843026","title":"Differentiation of rickettsiae by groEL gene analysis.","date":"2003","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12843026","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9512719","id":"PMC_9512719","title":"Thermodynamic stability and folding of GroEL minichaperones.","date":"1998","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9512719","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31800116","id":"PMC_31800116","title":"Iterative annealing mechanism explains the functions of the GroEL and RNA chaperones.","date":"2019","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/31800116","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10865174","id":"PMC_10865174","title":"Epitope mapping of heat shock protein 60 (GroEL) from Porphyromonas gingivalis.","date":"2000","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10865174","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29208924","id":"PMC_29208924","title":"HSP60 possesses a GTPase activity and mediates protein folding with HSP10.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29208924","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29415503","id":"PMC_29415503","title":"Physicochemical Properties of the Mammalian Molecular Chaperone HSP60.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29415503","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9166902","id":"PMC_9166902","title":"GroES binding regulates GroEL chaperonin activity under heat shock.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9166902","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29441825","id":"PMC_29441825","title":"Paraquat-induced inflammatory response of microglia through HSP60/TLR4 signaling.","date":"2018","source":"Human & experimental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/29441825","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25900372","id":"PMC_25900372","title":"Reaction Cycle of Chaperonin GroEL via Symmetric \"Football\" Intermediate.","date":"2015","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25900372","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7966230","id":"PMC_7966230","title":"An Hsp60 related protein is associated with purified HIV and SIV.","date":"1994","source":"Journal of medical primatology","url":"https://pubmed.ncbi.nlm.nih.gov/7966230","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9060401","id":"PMC_9060401","title":"Phylogenetic affinity of mitochondria of Euglena gracilis and kinetoplastids using cytochrome oxidase I and hsp60.","date":"1997","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/9060401","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17348040","id":"PMC_17348040","title":"NO-induced downregulation of HSP10 and HSP60 expression in the postischemic brain.","date":"2007","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/17348040","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23339303","id":"PMC_23339303","title":"Molecular chaperone disorders: defective Hsp60 in neurodegeneration.","date":"2012","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23339303","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30609639","id":"PMC_30609639","title":"CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30609639","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31963896","id":"PMC_31963896","title":"Curcumin Affects HSP60 Folding Activity and Levels in Neuroblastoma Cells.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31963896","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19022255","id":"PMC_19022255","title":"Direct regulation of HSP60 expression by c-MYC induces transformation.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19022255","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29295923","id":"PMC_29295923","title":"Folding of maltose binding protein outside of and in GroEL.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29295923","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20453921","id":"PMC_20453921","title":"Loss and gain of GroEL in the Mollicutes.","date":"2010","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/20453921","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18667427","id":"PMC_18667427","title":"An insecticidal GroEL protein with chitin binding activity from Xenorhabdus nematophila.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18667427","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15944406","id":"PMC_15944406","title":"Chaperonin GroEL meets the substrate protein as a \"load\" of the rings.","date":"2005","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15944406","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30584891","id":"PMC_30584891","title":"Inhibiting expression of HSP60 and TLR4 attenuates paraquat-induced microglial inflammation.","date":"2018","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/30584891","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28261350","id":"PMC_28261350","title":"Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.","date":"2017","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28261350","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33506187","id":"PMC_33506187","title":"Cryo-EM structure of human mitochondrial HSPD1.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/33506187","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26427351","id":"PMC_26427351","title":"Functional structure and physiological functions of mammalian wild-type HSP60.","date":"2015","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/26427351","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27882228","id":"PMC_27882228","title":"Oxymatrine inhibits microglia activation via HSP60-TLR4 signaling.","date":"2016","source":"Biomedical reports","url":"https://pubmed.ncbi.nlm.nih.gov/27882228","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19447897","id":"PMC_19447897","title":"Heat shock protein 60 (HSP60) stimulates neutrophil effector functions.","date":"2009","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/19447897","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36968544","id":"PMC_36968544","title":"Dissecting the Thermodynamics of ATP Binding to GroEL One Nucleotide at a Time.","date":"2023","source":"ACS central science","url":"https://pubmed.ncbi.nlm.nih.gov/36968544","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22038245","id":"PMC_22038245","title":"Identification and immunological characteristics of chaperonin GroEL in Riemerella anatipestifer.","date":"2011","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/22038245","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19470374","id":"PMC_19470374","title":"HSP60 interacts with YB-1 and affects its polysome association and subcellular localization.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19470374","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8636159","id":"PMC_8636159","title":"GroEL binds to and unfolds rhodanese posttranslationally.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8636159","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23770722","id":"PMC_23770722","title":"A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro.","date":"2013","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23770722","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28680529","id":"PMC_28680529","title":"miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1.","date":"2017","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/28680529","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7739666","id":"PMC_7739666","title":"Expression and localization of Trypanosoma cruzi hsp60.","date":"1994","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/7739666","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35245117","id":"PMC_35245117","title":"Protein chain collapse modulation and folding stimulation by GroEL-ES.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35245117","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27818197","id":"PMC_27818197","title":"Lenti-siRNA Hsp60 promote bax in mitochondria and induces apoptosis during heat stress.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27818197","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11716298","id":"PMC_11716298","title":"Mechanism of substrate recognition by the chaperonin GroEL.","date":"2001","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/11716298","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8098696","id":"PMC_8098696","title":"Insulitis-caused redistribution of heat-shock protein HSP60 inside beta-cells correlates with induction of HSP60 autoantibodies.","date":"1993","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/8098696","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16139196","id":"PMC_16139196","title":"Chaperomics: in vivo GroEL function defined.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16139196","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17979757","id":"PMC_17979757","title":"Chaperonin GroEL: structure and reaction cycle.","date":"2007","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/17979757","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28178129","id":"PMC_28178129","title":"Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28178129","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32766281","id":"PMC_32766281","title":"Complex Destabilization in the Mitochondrial Chaperonin Hsp60 Leads to Disease.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/32766281","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25056061","id":"PMC_25056061","title":"Biological insights from 108 schizophrenia-associated genetic loci.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25056061","citation_count":5878,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16964243","id":"PMC_16964243","title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.","date":"2006","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/16964243","citation_count":1336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26777405","id":"PMC_26777405","title":"ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26777405","citation_count":1233,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15635413","id":"PMC_15635413","title":"Nucleolar proteome dynamics.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15635413","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15592455","id":"PMC_15592455","title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15592455","citation_count":916,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19490893","id":"PMC_19490893","title":"A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19490893","citation_count":843,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11790298","id":"PMC_11790298","title":"Directed proteomic analysis of the human nucleolus.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11790298","citation_count":780,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26912792","id":"PMC_26912792","title":"An improved smaller biotin ligase for BioID proximity labeling.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/26912792","citation_count":665,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17110338","id":"PMC_17110338","title":"Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17110338","citation_count":517,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12665801","id":"PMC_12665801","title":"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12665801","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2568584","id":"PMC_2568584","title":"Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2568584","citation_count":479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32051585","id":"PMC_32051585","title":"Mechanical regulation of glycolysis via cytoskeleton architecture.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32051585","citation_count":445,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12887919","id":"PMC_12887919","title":"TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12887919","citation_count":442,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10205158","id":"PMC_10205158","title":"Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10205158","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42154,"output_tokens":6452,"usd":0.111621},"stage2":{"model":"claude-opus-4-6","input_tokens":10177,"output_tokens":3388,"usd":0.203377},"total_usd":0.716158,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":53630,"output_tokens":8838,"usd":0.14673},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":12694,"output_tokens":4246,"usd":0.25443}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"HSP60 (mitochondrial hsp60) is required for folding of proteins imported into mitochondria; folding occurs at the surface of hsp60 in an ATP-dependent reaction followed by release of bound polypeptides, establishing that hsp60 catalyses protein folding.\",\n      \"method\": \"In vitro folding assay with isolated mitochondria and purified hsp60; ATP hydrolysis measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational in vitro reconstitution with ATP hydrolysis assay; >576 citations; replicated across many subsequent studies\",\n      \"pmids\": [\"2528694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"HSP60 oligomeric assembly (14-mer double ring) requires pre-existing functional HSP60 complex — newly imported HSP60 subunits cannot self-assemble without the pre-existing chaperonin, demonstrating that hsp60 is required for its own assembly in an ATP-dependent catalysed reaction.\",\n      \"method\": \"Import assay into hsp60-defective yeast mutant (mif4); pulse-chase in intact cells and isolated mitochondria; native gel and sedimentation analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic mutant combined with in vitro import reconstitution; >169 citations\",\n      \"pmids\": [\"1978929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"ATP binding to one GroEL/HSP60 ring (positive cooperativity within the ring) triggers major conformational changes including domain tilting and twisting; GroES binding causes 100° twist of apical substrate-binding domains converting the hydrophobic cavity lining to hydrophilic, encapsulating the substrate for folding. ATP hydrolysis in the cis ring primes product release, and ATP binding in the trans ring disrupts the cis complex, releasing the substrate.\",\n      \"method\": \"X-ray crystallography of GroEL·GroES·(ADP)7 complex; cryo-EM of allosteric states; biochemical ATPase and folding assays\",\n      \"journal\": \"Annual review of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus extensive biochemical validation; >436 citations; replicated by multiple independent labs\",\n      \"pmids\": [\"9759498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"HSP60 physically associates with p21ras in vivo, identified as a 60-kDa cross-linking partner of Ras; association appears physiological as it does not increase proportionally with Ras overexpression.\",\n      \"method\": \"Chemical cross-linking, partial amino acid sequencing, cDNA cloning, cross-linking with order-of-addition experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — chemical cross-linking without reciprocal Co-IP confirmation; single lab\",\n      \"pmids\": [\"1347942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSP60 is released from cardiac myocytes via the exosomal pathway; within exosomes, HSP60 is tightly attached to the exosome membrane rather than being freely secreted via the classical Golgi-mediated pathway.\",\n      \"method\": \"Exosome isolation, fractionation, Western blot, electron microscopy; inhibition of classical secretory pathway\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation and localization experiment with functional pathway exclusion; single lab\",\n      \"pmids\": [\"17307989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSP60 stabilizes the mitochondrial pool of survivin (interaction identified by high-throughput proteomics); HSP60 siRNA ablation destabilizes survivin, induces mitochondrial dysfunction, and activates caspase-dependent apoptosis. HSP60 also forms a complex with p53 restraining p53 stabilization and downstream Bax-dependent apoptosis.\",\n      \"method\": \"High-throughput proteomics screening (Co-IP/MS), siRNA knockdown, Western blot, caspase activity assay, mitochondrial dysfunction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS-identified interaction confirmed by siRNA with multiple orthogonal cellular phenotype readouts; >223 citations\",\n      \"pmids\": [\"18086682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In cardiac cells, cytosolic HSP60 complexes with pro-apoptotic Bax and Bak (but not Bcl-2), and during hypoxia HSP60 redistributes from cytosol to the plasma membrane concurrent with cytochrome c release from mitochondria; reduction of HSP60 precipitates apoptosis without altering mitochondrial function. HSP60 also accelerates cleavage of pro-caspase-3.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, subcellular fractionation, hypoxia model, siRNA knockdown\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus localization with functional consequence; single lab, moderate evidence\",\n      \"pmids\": [\"15784164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 interacts with β-catenin via its apical domain, increases β-catenin protein levels, and enhances β-catenin transcriptional activity, promoting metastatic phenotypes; proteasomal activity is not required for HSP60-driven β-catenin accumulation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, transcriptional reporter assay, in vitro and in vivo metastasis assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with functional rescue and in vivo validation; single lab\",\n      \"pmids\": [\"19369584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HSP60 (mortalin/mtHsp70 interaction): HSP60 and mortalin/mtHsp70 physically interact both in vivo and in vitro; the N-terminal region of mortalin is involved; suppression of HSP60 by shRNA causes growth arrest of cancer cells similar to mortalin suppression.\",\n      \"method\": \"Co-immunoprecipitation, in vitro pulldown, shRNA knockdown, cell growth assay, co-localization by immunofluorescence\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with in vitro confirmation and N-terminal domain mapping; single lab\",\n      \"pmids\": [\"15957980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FUS physically interacts with HSP60 in mitochondria; FUS translocation to mitochondria is at least in part mediated by HSP60. Down-regulating HSP60 reduces mitochondrially localized FUS and partially rescues mitochondrial defects and neurodegenerative phenotypes caused by FUS in Drosophila.\",\n      \"method\": \"Co-immunoprecipitation, mitochondrial fractionation, Drosophila genetic rescue, live imaging\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical interaction plus genetic epistasis in vivo; single lab\",\n      \"pmids\": [\"26335776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Extracellular HSP60 induces inflammatory cytokine production in cardiomyocytes via TLR4-MyD88-p38-NF-κB pathway; it also up-regulates TLR2 and TLR4 expression through TLR4-MyD88-JNK-NF-κB pathway. Endogenous HSP60 released during ischemia triggers the same pathways.\",\n      \"method\": \"siRNA knockdown of TLR4/MyD88, pharmacological inhibitors, ELISA, Western blot, LAD ligation rat model\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitor approaches and genetic knockdown with in vivo confirmation; single lab\",\n      \"pmids\": [\"23447644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mitochondrial Lon protease associates with the Hsp60-mtHsp70 complex; Lon regulates the protein stability of this complex under oxidative stress, and Lon-mediated inhibition of apoptosis is dependent on Hsp60 binding to p53.\",\n      \"method\": \"Co-immunoprecipitation, shotgun mass spectrometry interactome, immunofluorescence co-localization, siRNA knockdown, apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — MS-identified interaction confirmed by Co-IP with functional epistasis; single lab\",\n      \"pmids\": [\"25675302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HSP60 and MnSOD physically interact; Hsp60 is required for proper folding of MnSOD, as heterozygous Hsp60 knockout increases oxidative stress in neuronal tissues associated with impaired MnSOD activity, establishing MnSOD as an HSP60 substrate.\",\n      \"method\": \"Co-immunoprecipitation, heterozygous knockout mouse model, enzyme activity assay, ROS measurement\",\n      \"journal\": \"Free radical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus loss-of-function mouse model with defined enzymatic readout; single lab\",\n      \"pmids\": [\"24151936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Homozygous inactivation of Hspd1 (encoding Hsp60) in mice causes early embryonic lethality (day 6.5–7.5), while heterozygous mice survive normally but show reduced Hsp60 protein; co-regulated Hsp10 (Hspe1) is also concomitantly down-regulated, demonstrating that Hspd1 is an essential mammalian gene.\",\n      \"method\": \"Gene-trap mouse knockout, quantitative RT-PCR, Western blot, embryo staging\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined developmental phenotype; multiple molecular readouts; replicated findings\",\n      \"pmids\": [\"20393889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HSP60 possesses an intrinsic GTPase activity in addition to ATPase activity; GTP affects allostery, complex formation with HSP10, and protein folding activity differently from ATP, revealing nucleotide-dependent differences in HSP60-HSP10 complex function.\",\n      \"method\": \"GTPase activity assay, ATPase assay, protein refolding assay, native PAGE, gel filtration\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay with mutagenesis/functional readout; single lab\",\n      \"pmids\": [\"29208924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mammalian HSP60 forms predominantly single-ring heptameric complexes in the absence of HSP10; in the presence of ATP and HSP10, HSP60 forms football- and bullet-type double-ring complexes. After ATP hydrolysis to ADP, HSP10 is released and double rings dissociate to single rings — a cycle distinct from the GroEL/GroES system.\",\n      \"method\": \"Electron microscopy, native PAGE, gel filtration, analytical ultracentrifugation, protein refolding assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with structural and biochemical characterization; single lab\",\n      \"pmids\": [\"29415503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mammalian wild-type HSP60 purified from porcine liver exists as a heptameric single-ring structure in the absence of ATP, and forms mainly a 'football-type' HSP60-HSP10 complex in the presence of ATP that mediates refolding of denatured substrates — functionally distinct from the GroEL/GroES double-ring bullet complex.\",\n      \"method\": \"Transmission electron microscopy, native PAGE, gel filtration, protein refolding assay with purified components\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct structural and biochemical reconstitution with purified native protein; single lab\",\n      \"pmids\": [\"26427351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cryo-EM structure of human mitochondrial HSPD1 in the apo state reveals that, unlike GroEL, HSPD1 forms mostly single-ring assemblies in the absence of co-chaperonin (HSPE1), with a rotated and more flexible apical domain compared to GroEL.\",\n      \"method\": \"Cryo-electron microscopy (cryo-EM) structural determination\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — primary cryo-EM structure of human HSPD1; direct structural evidence\",\n      \"pmids\": [\"33506187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gold(III) meso-tetraphenylporphyrin (gold-1a) directly binds to HSP60 and inhibits its chaperonin (protein refolding) activity; both the gold(III) ion and porphyrin ligand are required for HSP60 inhibition.\",\n      \"method\": \"Photo-affinity labeling, click chemistry, chemical proteomics, cellular thermal shift assay, saturation-transfer difference NMR, protein fluorescence quenching, protein chaperone refolding assay\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biophysical and biochemical methods confirming direct binding and functional inhibition\",\n      \"pmids\": [\"26663758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Myrtucommulone A (MC) directly binds HSP60 and prevents HSP60-mediated refolding of denatured malate dehydrogenase; MC binding causes aggregation of Lon protease (LONP) and LRP130 in isolated mitochondria under heat shock.\",\n      \"method\": \"Protein fishing (affinity pulldown) with MC as bait from mitochondrial lysates; protein refolding assay; mass spectrometry identification\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — affinity pulldown plus in vitro enzymatic inhibition assay; single lab\",\n      \"pmids\": [\"28457707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arsenic trioxide (ATO) directly binds HSP60, abolishes its protein refolding capability, and disrupts formation of HSP60-p53 and HSP60-survivin complexes, resulting in degradation of p53 and survivin.\",\n      \"method\": \"Metalloproteomics with organoarsenic probe, quantitative proteomics, biophysical binding assays, cell-based protein stability assays\",\n      \"journal\": \"Chemical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — chemical probe-based target identification combined with biophysical and cell-based functional validation; multiple orthogonal methods\",\n      \"pmids\": [\"34476069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 is localized in the mid-piece (mitochondria-rich region) of ejaculated human spermatozoa as determined by indirect immunofluorescence and subcellular fractionation; HSP60 is expressed in spermatogonia in the testis.\",\n      \"method\": \"Indirect immunofluorescence, Western blot of sperm subcellular fractions, immunohistochemistry, DNA microarray\",\n      \"journal\": \"International journal of andrology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization without direct functional consequence established\",\n      \"pmids\": [\"19207617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The disease-associated Hsp60 mutant p.Val98Ile (SPG13) has reduced chaperonin activity; cells expressing this mutant show decreased expression of mitochondrial proteases Lon and ClpP, suggesting compensatory adaptation to reduced Hsp60 function.\",\n      \"method\": \"Chaperonin activity assay of recombinant mutant protein, quantitative RT-PCR, Western blot in patient-derived cells, mitochondrial function assays\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — direct enzymatic activity measurement of disease mutant combined with patient cell analysis; single lab\",\n      \"pmids\": [\"18378094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HSP60 and survivin form complexes in both mitochondrial and cytosolic compartments in a cell-type dependent manner; in mitochondria, HSP60-survivin interaction involves CCAR2 and restrains p53-dependent apoptosis; HSP60 release from mitochondria to cytosol upon death stimuli promotes pro-apoptotic functions including Bax stabilization and procaspase-3 activation.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, siRNA knockdown, apoptosis assays\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with compartment-specific functional analysis; review/synthesis with some original data\",\n      \"pmids\": [\"31861751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 interacts with YB-1 at the YB-NLS region in the cytoplasm; when HSP60 expression is repressed, polysome-associated YB-1 increases in heavy-sedimenting fractions, and overexpression of HSP60 decreases YB-1 polysome association, indicating HSP60 regulates YB-1 subcellular distribution and translational activity.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient sedimentation, siRNA knockdown, overexpression studies\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with domain mapping and functional polysome readout; single lab\",\n      \"pmids\": [\"19470374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"c-MYC directly activates HSP60 transcription through an E-box (CACGTG) site in the proximal HSP60 promoter; overexpression of HSP60 induces cellular transformation, and siRNA-mediated HSP60 repression reduces c-MYC-driven transformation.\",\n      \"method\": \"Promoter reporter assay, ChIP, siRNA knockdown, transformation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding (ChIP) plus functional rescue by siRNA; single lab\",\n      \"pmids\": [\"19022255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HSPD1 knockdown or chemical inhibition by KHS101 induces drastic breakdown of oxidative phosphorylation and suppresses NSCLC cell proliferation in vitro and in vivo; genome-wide CRISPR/Cas9 screen shows HSPD1 anti-cancer effects are dependent on oxidative phosphorylation and linked to SLC6A8 and COX5B.\",\n      \"method\": \"CRISPR/Cas9 knockout, extracellular metabolic flux analysis, whole-genome CRISPR screen, drug profiling, transcriptomics, in vivo xenograft\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO with metabolic phenotype, genome-wide screen, in vivo validation; multiple orthogonal approaches\",\n      \"pmids\": [\"34364401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NO (from iNOS) suppresses HSP60 and HSP10 induction in the postischemic brain; the STAT3 binding site in the bidirectional HSP60/HSP10 promoter is responsible for LPS/IFN-γ-induced upregulation and for NO-mediated downregulation.\",\n      \"method\": \"Reporter gene analysis with promoter deletion and mutation studies, iNOS inhibitor (aminoguanidine), MCAO rat model, Western blot, RT-PCR\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter mutagenesis with in vivo pharmacological validation; single lab\",\n      \"pmids\": [\"17348040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Multiple post-translational modifications of HSP60 have been experimentally linked to functional consequences: phosphorylation affects sperm capacitation and mitochondrial dysfunction; nitration inhibits folding ability and affects mitochondrial permeability transition pore stability; acetylation is associated with mitochondrial failure; S-nitrosylation impacts mitochondrial stability; citrullination is pro-apoptotic; oxidation affects cell migration; ubiquitination regulates interaction with the ubiquitin-proteasome system.\",\n      \"method\": \"Various PTM-specific assays (phosphorylation, nitration, acetylation, S-nitrosylation, citrullination, oxidation, ubiquitination) across multiple studies reviewed\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — compiled from multiple experimental studies; evidence quality varies by PTM\",\n      \"pmids\": [\"32582761\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSPD1 (HSP60) is a mitochondrial chaperonin that, together with its co-chaperonin HSP10 (HSPE1), forms ATP-driven single- or double-ring complexes that bind unfolded or misfolded proteins via hydrophobic apical domain contacts, encapsulate them in a hydrophilic cavity upon HSP10 and ATP binding, and release them in a folded or partially folded state after ATP hydrolysis; in mammals HSP60 uniquely forms predominantly single rings in the apo state and football-type double-ring complexes upon ATP/HSP10 binding. Beyond its canonical mitochondrial protein folding role, cytosolic and extracellular HSP60 regulates apoptosis by forming complexes with survivin, p53, and Bax, signals through TLR4-NF-κB pathways when released extracellularly, and interacts with diverse partners including β-catenin, mortalin/mtHsp70, FUS, and YB-1 to influence cancer progression, neurodegeneration, and immune responses.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper and extract discoveries only from KEPT papers about HSPD1 (human HSP60/mitochondrial chaperonin).\n\n**Classification notes:**\n- Papers about bacterial GroEL/GroES orthologs describing the chaperonin mechanism → KEEP (foundational ortholog papers)\n- Papers about non-orthologous bacterial GroEL in specific organisms (Clostridium difficile adhesion, Xenorhabdus insecticidal, Burkholderia, rickettsiae diagnostics, Streptococcus vaccine, Riemerella, Mycobacterium leprae operon) → EXCLUDE (alias collision / non-orthologous function)\n- Papers about human/mammalian HSP60 → KEEP\n- Large proteomics/interactome screens (BioPlex, HuRI, etc.) with HSPD1 as incidental finding → EXCLUDE (no mechanistic findings about HSPD1)\n- GWAS schizophrenia, MGC cDNA, phosphoproteomics screens → EXCLUDE\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"Mitochondrial Hsp60 is required for the folding of proteins imported into mitochondria; folding occurs at the surface of Hsp60 in an ATP-hydrolysis-dependent reaction followed by release of the bound polypeptide, establishing Hsp60 as an ATP-dependent protein-folding catalyst in the mitochondrial matrix.\",\n      \"method\": \"In vitro import and folding assays in isolated yeast mitochondria; biochemical reconstitution\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro folding assay with ATP-dependence, foundational paper with 576 citations\",\n      \"pmids\": [\"2528694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"The primary structure of human mitochondrial HSP60 (P1) shows 40–50% sequence identity to bacterial GroEL, the mycobacterial 65 kDa antigen, and the chloroplast rubisco-binding protein, establishing HSP60 as the mammalian chaperonin homolog and suggesting a conserved posttranslational assembly role.\",\n      \"method\": \"cDNA cloning and sequence analysis; amino acid sequence alignment\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular characterization; 479 citations; establishes identity and homology of human HSPD1\",\n      \"pmids\": [\"2568584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Hsp60 monomers require pre-existing functional Hsp60 14-mer complexes for their own assembly into new 14-mer rings after mitochondrial import; assembly of newly imported subunits occurs with a half-time of 5–10 min and is thus a catalysed (not spontaneous) reaction.\",\n      \"method\": \"In vitro import into isolated mitochondria from hsp60-defective yeast mutant mif4; pulse-chase assembly assays; biochemical fractionation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in defined mutant background with kinetic analysis; 169 citations\",\n      \"pmids\": [\"1978929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Murine Hsp60 physically associates with p21ras in intact cells, as demonstrated by chemical cross-linking under conditions where mitochondrial Hsp60 release does not alter the amount complexed to p21ras, suggesting a physiological cytosolic interaction between Hsp60 and Ras.\",\n      \"method\": \"Chemical cross-linking followed by co-immunoprecipitation; cDNA cloning and partial amino acid sequencing to identify the 60 kDa binding partner\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single cross-linking/Co-IP experiment; moderate citation count\",\n      \"pmids\": [\"1347942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GroEL/Hsp60-mediated folding operates through: (1) binding of nonnative polypeptides at hydrophobic apical-domain sites, (2) ATP-binding-triggered conformational changes that encapsulate the substrate with GroES/Hsp10 in a cis ternary complex, (3) folding inside the sequestered cavity, (4) ATP hydrolysis in the cis ring priming product release, and (5) ATP binding to the trans ring dismantling the cis complex—enabling iterative recycling of non-native substrates.\",\n      \"method\": \"Structural crystallography, cryo-EM, biochemical ATPase assays, mutational analysis — comprehensive mechanistic review synthesizing multiple experimental approaches\",\n      \"journal\": \"Protein science : a publication of the Protein Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods across many labs; >300 citations; replicated mechanism\",\n      \"pmids\": [\"9098884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The GroEL-GroES complex undergoes major asymmetric conformational changes upon ATP binding: apical domain twisting removes hydrophobic substrate-binding sites from the cavity lining and creates a hydrophilic folding chamber; ATP hydrolysis is not needed for a single round of encapsulation but is required for trans-ring ATP binding to dismantle the cis complex and release substrate.\",\n      \"method\": \"X-ray crystallography of GroEL·GroES·(ADP)7 complex; cryo-EM of allosteric states; biochemical ATPase assays\",\n      \"journal\": \"Annual review of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus biochemical validation; replicated; 436 citations\",\n      \"pmids\": [\"9759498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pro-caspase-3 is present in mitochondria in a complex with Hsp60 and Hsp10; upon induction of apoptosis, pro-caspase-3 dissociates from the Hsps, which are released from mitochondria. Recombinant Hsp60 and Hsp10 accelerate activation of pro-caspase-3 by cytochrome c and dATP in an ATP-dependent manner in vitro.\",\n      \"method\": \"Co-immunoprecipitation from mitochondrial fractions; in vitro caspase activation assay with recombinant proteins; subcellular fractionation; Western blot\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP plus reconstituted in vitro activation assay; 438 citations\",\n      \"pmids\": [\"10205158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GroEL induces structural rearrangements in a nonnative RuBisCO intermediate: it first partially unfolds or expands the substrate upon capture, then spatially constricts it within the GroEL-GroES cavity, driving the substrate toward compact, folding-competent states. This two-step mechanism (expansion then compression) is ATP- and GroES-dependent.\",\n      \"method\": \"Fluorescence resonance energy transfer (FRET) between amino- and carboxy-terminal domains of RuBisCO; low-temperature trapping of monomeric non-aggregating intermediate; kinetic reactivation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — FRET with functional reactivation assay; mechanistic dissection with multiple controls\",\n      \"pmids\": [\"15469819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Mortalin/mtHsp70 and HSP60 interact both in vivo and in vitro; the N-terminal region of mortalin mediates this interaction. Both proteins co-localize in mitochondria, and suppression of HSP60 expression causes cancer cell growth arrest similar to mortalin suppression.\",\n      \"method\": \"Co-immunoprecipitation in vivo and in vitro; shRNA-mediated knockdown; immunofluorescence co-localization\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal Co-IP plus domain mapping and functional KD; single lab\",\n      \"pmids\": [\"15957980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HSP60 is released from adult cardiac myocytes via the exosomal pathway; within exosomes, HSP60 is tightly attached to the exosomal membrane. The classic Golgi-mediated secretory pathway is not responsible for HSP60 release.\",\n      \"method\": \"Exosome isolation; electron microscopy; Western blot of exosomal fractions; pathway inhibitor studies ruling out classical secretion\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation and localization with functional pathway dissection; 299 citations\",\n      \"pmids\": [\"17307989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Hsp60 maintains a mitochondrial pool of survivin (stabilizing it) and forms a complex with p53 that restrains p53 function; siRNA ablation of Hsp60 destabilizes mitochondrial survivin, disrupts the Hsp60-p53 complex causing p53 stabilization, increases pro-apoptotic Bax expression, and activates caspase-dependent apoptosis selectively in tumor cells.\",\n      \"method\": \"High-throughput proteomics screening; siRNA knockdown; Co-immunoprecipitation; mitochondrial fractionation; caspase activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — proteomics plus Co-IP plus functional siRNA with specific apoptotic readouts; 223 citations\",\n      \"pmids\": [\"18086682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 interacts with β-catenin via its apical domain, increases β-catenin protein levels, and enhances β-catenin transcriptional activity to promote metastatic phenotypes in vitro and in vivo; siRNA-mediated repression of β-catenin reverts HSP60-induced metastasis, and this effect is independent of proteasomal activity.\",\n      \"method\": \"Co-immunoprecipitation; overexpression and siRNA knockdown; in vitro invasion assays; in vivo metastasis assays; domain mapping\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with domain mapping plus loss- and gain-of-function; single lab; 101 citations\",\n      \"pmids\": [\"19369584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HSP60 interacts with YB-1 at the YB-NLS region in the cytoplasm; this interaction regulates the polysome association and subcellular distribution of YB-1: knockdown of HSP60 increases polysome-associated YB-1, while HSP60 overexpression decreases YB-1 in heavy-sedimenting polysome fractions and suppresses YB-NLS nuclear translocation activity.\",\n      \"method\": \"Co-immunoprecipitation; sucrose gradient sedimentation; siRNA knockdown; overexpression; subcellular fractionation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP plus functional KD/OE with polysome fractionation; single lab\",\n      \"pmids\": [\"19470374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Homozygous inactivation of the Hspd1 gene in mice causes early embryonic lethality shortly after implantation (E6.5–7.5), demonstrating that Hspd1 is an essential gene for mammalian embryonic development; heterozygous mice show reduced Hsp60 and Hsp10 protein levels but survive normally.\",\n      \"method\": \"Gene-trap mouse knockout; genotyping; quantitative RT-PCR; Western blot; embryo staging\",\n      \"journal\": \"Cell stress & chaperones\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined lethal phenotype and confirmed knockdown; 70 citations\",\n      \"pmids\": [\"20393889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Extracellular HSP60 induces inflammatory cytokine production in cardiomyocytes via TLR4–MyD88–p38/NF-κB signaling, and upregulates TLR2/4 expression via TLR4–MyD88–JNK/NF-κB signaling. During ischemia, endogenous HSP60 released extracellularly triggers the same pathways to promote myocardial inflammation.\",\n      \"method\": \"Cytokine ELISA; TLR blocking antibodies; pathway inhibitors (p38, JNK, NF-κB); siRNA for MyD88/TLR4; rat LAD ligation model\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal pathway inhibition experiments with in vitro and in vivo confirmation; 97 citations\",\n      \"pmids\": [\"23447644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hsp60 interacts with manganese superoxide dismutase (MnSOD) and is required for proper MnSOD folding; in a heterozygous Hsp60-knockout mouse model, reduced Hsp60 availability leads to impaired MnSOD function and increased oxidative stress in neuronal tissues, identifying MnSOD as a substrate of the Hsp60 folding machinery.\",\n      \"method\": \"Co-immunoprecipitation; heterozygous knockout mouse model; ROS measurements; enzymatic activity assays for MnSOD\",\n      \"journal\": \"Free radical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus KO model with functional readout; single lab\",\n      \"pmids\": [\"24151936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The GroEL-GroES2 'football' complex (symmetric, both rings capped) is the protein-folding functional form. Substrate protein-catalyzed ADP/ATP exchange enables both chambers to encapsulate substrate efficiently when substrate binding precedes ATP. The two rings of GroEL function as a parallel processing machine in this form, differing conformationally from the asymmetric 'bullet' complex at both the GroEL-GroES interface and the inter-ring interface.\",\n      \"method\": \"Cryo-EM structure determination (~3.7 Å); calibrated FRET; order-of-addition biochemical experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — near-atomic cryo-EM structure plus orthogonal biochemical validation\",\n      \"pmids\": [\"25136110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FUS (ALS/FTLD-associated RNA-binding protein) interacts with HSP60 and uses this interaction to translocate to mitochondria; downregulating HSP60 reduces mitochondrially localized FUS and partially rescues mitochondrial defects and neurodegenerative phenotypes caused by FUS in transgenic Drosophila.\",\n      \"method\": \"Co-immunoprecipitation; biochemical fractionation; HSP60 siRNA knockdown; transgenic Drosophila genetics; mitochondrial morphology assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus genetic epistasis in Drosophila model; multiple orthogonal methods; 155 citations\",\n      \"pmids\": [\"26335776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Gold(III) porphyrin (gold-1a) directly targets and inhibits Hsp60 chaperonin activity in vitro and in cells; inhibition of Hsp60 by gold-1a depends on both the gold(III) ion and the porphyrin ligand working together, as shown by structure-activity studies with non-porphyrin gold(III) complexes and other metalloporphyrins.\",\n      \"method\": \"Photo-affinity labeling; click chemistry; chemical proteomics; cellular thermal shift assay; saturation-transfer difference NMR; protein fluorescence quenching; protein chaperone refolding assay\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biophysical and biochemical methods confirming direct target engagement and functional inhibition\",\n      \"pmids\": [\"26663758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mitochondrial Lon protease associates with the Hsp60-mtHsp70 chaperone complex; Lon maintains protein stability/levels of the Hsp60-mtHsp70 complex under oxidative stress, and Lon's ability to inhibit apoptosis depends on Hsp60 binding to p53.\",\n      \"method\": \"Co-immunoprecipitation; shotgun mass spectrometry interactome; immunofluorescence co-localization; siRNA knockdown; apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — proteomics interactome confirmed by Co-IP plus functional dependency experiments; single lab\",\n      \"pmids\": [\"25675302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Wild-type mammalian HSP60 forms heptameric single-ring structures in the absence of ATP, but forms predominantly football-type (symmetric double-ring) complexes with HSP10 in the presence of ATP. After ATP hydrolysis to ADP, HSP60 releases HSP10 and the double-ring dissociates to single rings, demonstrating an ATP-dependent single-ring ↔ double-ring transition distinct from the bacterial GroEL/GroES cycle.\",\n      \"method\": \"Purification from porcine liver; transmission electron microscopy; native PAGE; gel filtration; protein refolding assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified wild-type protein with structural (TEM) and biochemical validation; demonstrates key mechanistic difference from GroEL\",\n      \"pmids\": [\"26427351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Myrtucommulone A (MC) directly binds HSP60 and inhibits its protein refolding activity; HSP60 inhibition by MC leads to aggregation of Lon protease-like protein (LONP) and leucine-rich PPR motif-containing protein (LRP130) in isolated mitochondria, identifying these as HSP60-dependent substrates.\",\n      \"method\": \"Protein fishing/affinity pulldown with MC as bait; protein refolding assay (malate dehydrogenase); 2D gel electrophoresis and MS identification of aggregated proteins in isolated mitochondria\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro refolding assay plus substrate identification in organellar system; multiple orthogonal approaches\",\n      \"pmids\": [\"28457707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HSP60 possesses GTPase activity in addition to its established ATPase activity; GTP alters HSP60 allostery, complex formation with HSP10, and protein folding activity differently than ATP, providing evidence for nucleotide-dependent functional modulation of the HSP60-HSP10 complex.\",\n      \"method\": \"GTPase activity assay; ATPase assay; native PAGE; protein folding reactivation assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay; single lab without independent replication\",\n      \"pmids\": [\"29208924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"miR-382 targets the 3′-UTR of HSPD1 mRNA, downregulating HSP60 protein expression; HSPD1 knockdown promotes oxidative stress by reducing thioredoxin (Trx) expression, while HSPD1 overexpression restores Trx levels and reverses TGF-β1-induced loss of E-cadherin, placing HSPD1 upstream of the Trx antioxidant pathway in renal fibrosis.\",\n      \"method\": \"miR-382 mimic/anti-miR; HSPD1 siRNA knockdown; HSPD1 overexpression; luciferase reporter (3′-UTR target validation); UUO mouse model; Western blot; redox markers\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — validated miRNA target with gain- and loss-of-function and in vivo confirmation; single lab\",\n      \"pmids\": [\"28680529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Mammalian HSP60 undergoes nucleotide-dependent assembly: HSP10 binding promotes HSP60 double-ring formation in the presence of ATP; after ATP hydrolysis to ADP, HSP10 is released and double-rings dissociate to single rings. This structural transition is highly distinctive from GroEL/GroES, particularly in complex formation mode and the roles of ATP binding versus hydrolysis.\",\n      \"method\": \"Multiple analytical techniques under near-physiological conditions: native MS, DLS, analytical ultracentrifugation, fluorescence; ATP/ADP titration experiments\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biophysical methods confirming nucleotide-dependent ring transitions under physiological conditions\",\n      \"pmids\": [\"29415503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GroEL undergoes transient ring separation (ring exchange between complexes) upon ATP binding to the trans ring, driven by inter-ring negative allostery. A GroEL mutant unable to perform ring separation remains folding-active but populates symmetric GroEL:GroES2 football complexes where both rings function simultaneously rather than sequentially, leading to inefficient substrate binding/release and impaired E. coli growth.\",\n      \"method\": \"FRET-based ring exchange assay; GroEL ring-separation mutant; in vivo E. coli growth complementation; native gel electrophoresis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — engineered mutant with defined biochemical and in vivo phenotype; mechanistically rigorous\",\n      \"pmids\": [\"29336887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Simple encapsulation of maltose binding protein (MBP) within the GroEL/ES cavity repairs a defined folding defect (V9G mutation that disrupts a preintermediate hydrophobic cluster) and restores wild-type folding rates, with or without ATP-driven cycling. This reveals a folding mechanism based on nonspecific equilibrium compression/confinement within the cavity rather than unfolding of misfolded intermediates.\",\n      \"method\": \"Hydrogen exchange-mass spectrometry (HX-MS); fluorescence refolding kinetics; site-directed mutagenesis; comparison of free-solution vs. cavity-encapsulated folding\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — HX-MS with mutagenesis defining the structural mechanism; orthogonal validation\",\n      \"pmids\": [\"29295923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HSP60-survivin complexes exist in both cytosolic and mitochondrial compartments in a cell-type-dependent manner. In mitochondria, HSP60 promotes survival by stabilizing survivin and interacting with CCAR2 and p53. When HSP60 is released from mitochondria to cytosol upon death stimuli, it can promote apoptosis by stabilizing Bax, enhancing pro-caspase-3 activation, or increasing protein ubiquitination.\",\n      \"method\": \"Subcellular fractionation; Co-immunoprecipitation; siRNA knockdown; apoptosis assays; literature synthesis with mechanistic framework\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and fractionation data combined with review synthesis; mechanistic conclusions partly inferential\",\n      \"pmids\": [\"31861751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cryo-EM structure of human mitochondrial HSPD1 in the apo state reveals that, unlike bacterial GroEL (which exists as double rings), HSPD1 forms mostly single-ring assemblies in the absence of co-chaperonin HSPE1. Comparison with GroEL shows a rotation and increased flexibility of the apical domain in HSPD1.\",\n      \"method\": \"Cryo-electron microscopy; 3D reconstruction and comparison with GroEL structures\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure revealing key structural distinction from prokaryotic homolog\",\n      \"pmids\": [\"33506187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Disease-associated point mutations in HSPD1 (D29G and V98I linked to hereditary spastic paraplegia/hypomyelinating leukodystrophy) act primarily by destabilizing the oligomeric stability of the mtHsp60 complex rather than globally unfolding the monomer, suggesting oligomeric integrity is essential for folding function and neuronal survival.\",\n      \"method\": \"Biophysical characterization of purified mutant proteins; native gel electrophoresis; thermal stability assays; structural modeling; literature synthesis\",\n      \"journal\": \"Frontiers in molecular biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — biochemical characterization of disease mutants; single lab; 21 citations\",\n      \"pmids\": [\"32766281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HSPD1 knockdown or chemical disruption by small molecule KHS101 induces a drastic breakdown of oxidative phosphorylation (OXPHOS) and suppresses NSCLC proliferation in vitro and in vivo. A genome-wide CRISPR/Cas9 screen validated that KHS101 anti-cancer effects are dependent on OXPHOS, with SLC6A8 (creatine transporter) and COX5B (cytochrome c oxidase subunit) as determinants of sensitivity.\",\n      \"method\": \"HSPD1 CRISPR/Cas9 knockout; siRNA knockdown; KHS101 pharmacological inhibition; extracellular metabolic flux analysis (Seahorse); genome-wide CRISPR/Cas9 drug sensitivity screen; in vivo xenograft\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic KO plus pharmacological inhibition plus CRISPR screen plus metabolic phenotyping; multiple orthogonal approaches\",\n      \"pmids\": [\"34364401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Arsenic trioxide (ATO) binds directly to Hsp60 and abolishes its protein refolding capability; ATO binding disrupts the Hsp60-p53 and Hsp60-survivin complexes, resulting in degradation of both p53 and survivin in APL cells.\",\n      \"method\": \"Organoarsenic chemical probe metalloproteomics; quantitative proteomics; cellular thermal shift assay; biophysical binding assays; cell-based p53/survivin stability assays; protein refolding assay\",\n      \"journal\": \"Chemical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct target identification with multiple biophysical methods plus functional consequence in cells\",\n      \"pmids\": [\"34476069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GroEL-ES accelerates protein folding by strengthening polypeptide chain collapse: GroEL induces contractile forces in substrate chains drawing them into the cavity and triggering compaction and discrete folding transitions. Collapse enhancement is strongest in nucleotide-bound states, aided by GroES at the cavity rim and amphiphilic C-terminal tails at the cavity bottom. This mechanism is distinct from steric confinement and misfold-unfolding mechanisms.\",\n      \"method\": \"Integrated optical tweezers protein manipulation; single-molecule fluorescence imaging; nucleotide state-specific measurements; GroES binding assays\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-molecule manipulation with direct force measurement; mechanistic dissection of distinct folding contributions\",\n      \"pmids\": [\"35245117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Patient cells heterozygous for the c.292G>A HSPD1 allele encoding Hsp60-p.Val98Ile show decreased expression of mitochondrial proteases Lon and ClpP at both RNA and protein levels, suggesting a compensatory cellular adaptation to reduced Hsp60 chaperonin activity that allows substrate proteins more folding attempts before degradation.\",\n      \"method\": \"qRT-PCR; Western blot; mitochondrial membrane potential; oxidative stress assays in lymphoblastoid and fibroblast cell lines from SPG13 patient\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — patient-derived cells with multiple molecular readouts; single patient/lab\",\n      \"pmids\": [\"18378094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cytosolic HSP60 in cardiac cells forms complexes with Bax, Bak, and Bcl-XL (but not Bcl-2) under normal conditions; during hypoxia, HSP60 redistributes from cytosol to the plasma membrane, coinciding with cytochrome c release from mitochondria prior to reoxygenation. Reduction in HSP60 expression precipitates apoptosis without altering mitochondrial function. Additionally, HSP60 accelerates cleavage of pro-caspase-3.\",\n      \"method\": \"Co-immunoprecipitation; subcellular fractionation; siRNA knockdown; hypoxia-reoxygenation model; immunofluorescence\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus fractionation plus functional KD; 145 citations; single lab\",\n      \"pmids\": [\"15784164\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HSPD1 (mitochondrial HSP60) is an ATP-dependent Group I chaperonin that forms heptameric single rings (apo state) or football-type double rings with co-chaperonin HSPE1/Hsp10 in the presence of ATP; it binds non-native polypeptides at hydrophobic apical-domain sites, encapsulates them in a hydrophilic folding cavity upon ATP-driven conformational changes, promotes folding through cavity confinement and chain-collapse enhancement, and releases substrates after ATP hydrolysis and inter-ring allosteric signaling. Beyond canonical mitochondrial protein folding (including substrates such as MnSOD, LONP, and LRP130), HSP60 has established extra-mitochondrial roles: it forms complexes with survivin, p53, Bax/Bak/Bcl-XL, pro-caspase-3, mortalin/mtHsp70, β-catenin, and YB-1 to regulate apoptosis and cell survival; it is secreted via exosomes and signals extracellularly through TLR4–MyD88–NF-κB pathways to drive inflammation; and loss-of-function mutations (e.g., V98I, D29G) that destabilize the oligomeric complex cause hereditary spastic paraplegia (SPG13) and hypomyelinating leukodystrophy, while complete HSPD1 knockout is embryonic lethal in mice.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HSPD1 (HSP60) is a mitochondrial chaperonin essential for the folding of imported mitochondrial proteins and for cellular viability. Together with its co-chaperonin HSPE1 (HSP10), HSPD1 forms ATP-driven heptameric single-ring complexes that transition to football-type double rings upon nucleotide and HSPE1 binding, encapsulating unfolded substrates in a hydrophilic cavity for assisted folding — a cycle mechanistically distinct from the bacterial GroEL/GroES system [PMID:2528694, PMID:29415503, PMID:33506187]. Beyond canonical mitochondrial chaperonin function, cytosolic and extracellular pools of HSPD1 regulate apoptosis through complexes with survivin, p53, and Bax, and extracellular HSPD1 activates innate immune signaling via TLR4-NF-κB [PMID:18086682, PMID:15784164, PMID:23447644]. Homozygous disruption of Hspd1 in mice causes early embryonic lethality, and the disease-associated p.Val98Ile mutation (SPG13) reduces chaperonin activity, linking HSPD1 loss of function to hereditary spastic paraplegia [PMID:20393889, PMID:18378094].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"The foundational question of whether mitochondrial protein folding is catalyzed was answered by demonstrating that HSP60 binds imported polypeptides and releases them in an ATP-dependent reaction, establishing HSP60 as a bona fide protein-folding machine.\",\n      \"evidence\": \"In vitro folding assay with isolated yeast mitochondria and purified hsp60, measuring ATP hydrolysis\",\n      \"pmids\": [\"2528694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate specificity and range of obligate substrates not defined\", \"Mechanism of co-chaperonin cooperation not yet addressed\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Whether HSP60 assembly is self-sufficient was resolved: newly imported HSP60 subunits require pre-existing functional HSP60 oligomers for assembly, establishing that the chaperonin is its own substrate.\",\n      \"evidence\": \"Import assay into hsp60-defective yeast mutant (mif4) with native gel and sedimentation analysis\",\n      \"pmids\": [\"1978929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the initial HSP60 complex forms during mitochondrial biogenesis in the embryo remains unaddressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"The structural basis of the chaperonin folding cycle was elucidated: ATP binding drives allosteric domain rearrangements, GroES/HSP10 binding converts the cavity from hydrophobic to hydrophilic for substrate encapsulation, and trans-ring ATP binding triggers product release.\",\n      \"evidence\": \"X-ray crystallography of GroEL·GroES·(ADP)7 complex combined with cryo-EM and biochemical ATPase/folding assays\",\n      \"pmids\": [\"9759498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"These structures were of bacterial GroEL; whether mammalian HSP60 uses the same double-ring mechanism was unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"HSP60 was shown to function outside the mitochondrial matrix — cytosolic HSP60 complexes with pro-apoptotic Bax/Bak and its knockdown triggers apoptosis, establishing a non-canonical role in apoptosis regulation.\",\n      \"evidence\": \"Co-immunoprecipitation, subcellular fractionation, and hypoxia/siRNA studies in cardiac cells\",\n      \"pmids\": [\"15784164\", \"15957980\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which HSP60 exits mitochondria to the cytosol not defined\", \"Stoichiometry and affinity of HSP60-Bax interaction not quantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The route of extracellular HSP60 release was identified as exosomal rather than classical secretory, and extracellular HSP60 was shown to signal through TLR4-MyD88-NF-κB to induce inflammation, establishing HSP60 as a damage-associated molecular pattern.\",\n      \"evidence\": \"Exosome isolation/fractionation from cardiac myocytes; TLR4/MyD88 siRNA and pharmacological inhibition with in vivo ischemia model\",\n      \"pmids\": [\"17307989\", \"23447644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether exosomal HSP60 retains chaperonin activity extracellularly is unknown\", \"Contribution of potential endotoxin contamination not fully excluded in all TLR4 studies\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"HSP60 was linked to anti-apoptotic signaling through proteomics-identified complexes with survivin and p53: HSP60 stabilizes mitochondrial survivin and restrains p53, with its depletion activating caspase-dependent cell death.\",\n      \"evidence\": \"High-throughput Co-IP/MS, siRNA knockdown with caspase activity and mitochondrial dysfunction readouts\",\n      \"pmids\": [\"18086682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSP60 folds survivin/p53 as chaperonin substrates or acts as a scaffolding partner is unclear\", \"In vivo cancer relevance of this axis not demonstrated at this point\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The disease-associated SPG13 mutation (p.Val98Ile) was shown to directly reduce HSP60 chaperonin activity, providing a molecular mechanism for hereditary spastic paraplegia caused by HSPD1 mutations.\",\n      \"evidence\": \"Recombinant mutant protein chaperonin assay combined with patient-derived cell analysis\",\n      \"pmids\": [\"18378094\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which specific mitochondrial substrates are misfolded in SPG13 neurons is unknown\", \"No animal model of the point mutation was generated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Essentiality of HSPD1 was definitively established: homozygous knockout in mice causes embryonic lethality at E6.5–7.5, and heterozygotes show coordinately reduced HSP60 and HSP10 protein levels.\",\n      \"evidence\": \"Gene-trap knockout mouse with embryo staging, qRT-PCR, and Western blot\",\n      \"pmids\": [\"20393889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific conditional knockouts not reported\", \"Whether lethality reflects mitochondrial proteostasis collapse or an alternative HSP60 function was not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"HSP60 was identified as a folding chaperone for MnSOD (SOD2): heterozygous Hsp60 knockout mice show impaired MnSOD activity and elevated oxidative stress in neuronal tissue, linking HSP60 to mitochondrial antioxidant defense.\",\n      \"evidence\": \"Co-IP plus heterozygous knockout mouse with MnSOD enzyme activity and ROS measurements\",\n      \"pmids\": [\"24151936\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MnSOD is a direct folding substrate or stabilized indirectly is not fully resolved\", \"Contribution of other chaperones to MnSOD folding not excluded\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A key distinction of mammalian HSP60 from bacterial GroEL was established: native HSP60 exists predominantly as single heptameric rings that form football-type double rings only upon ATP/HSP10 binding, with ring dissociation upon hydrolysis — a fundamentally different reaction cycle.\",\n      \"evidence\": \"TEM, native PAGE, gel filtration, and refolding assays of purified native porcine HSP60 and recombinant human HSP60\",\n      \"pmids\": [\"26427351\", \"29415503\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full atomic-resolution structure of the football complex not available at this point\", \"Whether single-ring intermediates are active folders in vivo is untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"HSP60 was found to mediate mitochondrial translocation of the ALS-linked protein FUS; reducing HSP60 rescued FUS-induced neurodegeneration in Drosophila, identifying HSP60 as a contributor to FUS-mediated neurotoxicity.\",\n      \"evidence\": \"Co-IP, mitochondrial fractionation, and Drosophila genetic rescue with live imaging\",\n      \"pmids\": [\"26335776\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct import mechanism for FUS via HSP60 not characterized biochemically\", \"Not confirmed in mammalian models of ALS\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cryo-EM of human HSPD1 resolved the apo-state single-ring structure at near-atomic resolution, revealing a rotated and more flexible apical domain compared to GroEL, providing a structural explanation for the single-ring preference of the mammalian chaperonin.\",\n      \"evidence\": \"Cryo-EM structural determination of human mitochondrial HSPD1\",\n      \"pmids\": [\"33506187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures of substrate-bound and HSP10-bound states of human HSPD1 not yet determined\", \"Dynamics of ring-ring association during folding cycle not captured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Chemical biology approaches demonstrated that HSP60 inhibition (by arsenic trioxide, gold porphyrins, or KHS101) disrupts both its chaperonin folding activity and its protein-protein interactions with survivin and p53, collapsing oxidative phosphorylation and suppressing cancer cell growth.\",\n      \"evidence\": \"Metalloproteomics, CRISPR screens, metabolic flux analysis, and in vivo xenograft models\",\n      \"pmids\": [\"34476069\", \"34364401\", \"26663758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity of these inhibitors for HSP60 over other chaperones in vivo not fully characterized\", \"Therapeutic window for HSP60 inhibition given its essentiality in normal cells not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the complete catalog of obligate HSP60 folding substrates in human mitochondria, the structural basis of substrate recognition and encapsulation by the mammalian single-ring system, and the molecular mechanism by which HSP60 exits mitochondria to access cytosolic and extracellular compartments.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full substrate repertoire undefined\", \"No structure of human HSP60-HSP10-substrate ternary complex\", \"Mitochondrial export mechanism unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 2, 15, 16, 17, 18]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 2, 14, 15]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 1, 5, 9, 12, 17, 21]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 23, 24]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 10]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 12, 15, 16, 17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5, 6, 23]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [\n      \"HSP60-HSP10 chaperonin complex\",\n      \"HSP60-mtHsp70-Lon complex\"\n    ],\n    \"partners\": [\n      \"HSPE1\",\n      \"HSPA9\",\n      \"TP53\",\n      \"BIRC5\",\n      \"BAX\",\n      \"CTNNB1\",\n      \"FUS\",\n      \"YBX1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HSPD1 encodes the mitochondrial 60 kDa chaperonin (HSP60), an ATP-dependent Group I chaperonin essential for folding proteins imported into the mitochondrial matrix and for maintaining mitochondrial proteostasis, with additional extra-mitochondrial roles in apoptosis regulation and innate immune signaling. HSP60 binds non-native polypeptides at hydrophobic apical-domain sites, undergoes ATP-driven conformational changes to encapsulate substrates with co-chaperonin HSPE1/HSP10 in a hydrophilic folding cavity, and promotes folding through chain-collapse enhancement and cavity confinement before releasing substrates upon ATP hydrolysis; unlike bacterial GroEL, mammalian HSP60 exists as single heptameric rings in the apo state and assembles into symmetric double-ring \\\"football\\\" complexes only upon ATP binding and HSP10 association [PMID:2528694, PMID:26427351, PMID:29295923, PMID:35245117]. Outside the mitochondrial matrix, HSP60 forms complexes with survivin, p53, and Bax/Bak to regulate apoptosis in a compartment-dependent manner—stabilizing survivin and restraining p53 in mitochondria while promoting caspase-3 activation upon cytosolic release—and is secreted via exosomes to activate TLR4–MyD88–NF-κB inflammatory signaling [PMID:10205158, PMID:18086682, PMID:17307989, PMID:23447644]. Loss-of-function mutations (D29G, V98I) that destabilize HSP60 oligomeric integrity cause hereditary spastic paraplegia (SPG13) and hypomyelinating leukodystrophy, and homozygous knockout is embryonic lethal in mice [PMID:32766281, PMID:20393889].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"The foundational question of whether mitochondrial protein folding requires a dedicated catalyst was answered: HSP60 mediates ATP-dependent folding of imported mitochondrial proteins, establishing it as the first defined intracellular chaperonin.\",\n      \"evidence\": \"In vitro import and folding assays in isolated yeast mitochondria plus cDNA cloning confirming mammalian homology to GroEL\",\n      \"pmids\": [\"2528694\", \"2568584\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate range of mitochondrial HSP60 undefined\", \"Mechanism of ATP coupling to folding unknown\", \"Co-chaperonin requirement not yet addressed\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Whether HSP60 oligomer assembly is spontaneous or assisted was resolved: newly imported HSP60 monomers require pre-existing functional 14-mer complexes for their own assembly, revealing a self-templating oligomerization mechanism.\",\n      \"evidence\": \"Import into mitochondria from hsp60-defective yeast mutant mif4 with pulse-chase assembly kinetics\",\n      \"pmids\": [\"1978929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of assisted assembly unknown\", \"Stoichiometric requirements for template not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The complete chaperonin reaction cycle was delineated: substrate capture at hydrophobic apical sites, ATP-driven encapsulation with HSP10/GroES forming a cis ternary complex, folding in the sealed cavity, ATP hydrolysis priming release, and trans-ring ATP binding dismantling the complex for iterative recycling.\",\n      \"evidence\": \"Crystallography, cryo-EM, ATPase assays, and mutational analysis across multiple laboratories synthesized into a unified mechanism\",\n      \"pmids\": [\"9098884\", \"9759498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the cavity environment actively promotes folding (beyond passive confinement) was unresolved\", \"Mammalian-specific differences from GroEL not yet characterized\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"HSP60's role was extended beyond canonical folding to apoptosis regulation: HSP60 and HSP10 form a mitochondrial complex with pro-caspase-3 and accelerate its activation by cytochrome c in vitro, establishing HSP60 as a direct participant in caspase-dependent cell death.\",\n      \"evidence\": \"Co-immunoprecipitation from mitochondrial fractions and reconstituted in vitro caspase activation assay\",\n      \"pmids\": [\"10205158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSP60 promotes or inhibits apoptosis appeared context-dependent and unresolved\", \"Mechanism of HSP60 release from mitochondria unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The scope of HSP60's anti-apoptotic partnerships was broadened: cytosolic HSP60 complexes with Bax, Bak, and Bcl-XL in cardiac cells, and mitochondrial HSP60 interacts with mortalin/mtHsp70, with knockdown of either protein arresting cancer cell growth.\",\n      \"evidence\": \"Co-immunoprecipitation, subcellular fractionation, siRNA knockdown in cardiac and cancer cell lines\",\n      \"pmids\": [\"15784164\", \"15957980\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs. indirect nature of Bax/Bak binding not resolved\", \"Functional consequence of mortalin–HSP60 interaction on specific substrates unclear\", \"Whether HSP60 chaperone activity is required for these interactions not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Two outstanding questions were answered: how HSP60 reaches the extracellular space and what it does there. HSP60 is released via exosomes from cardiac myocytes, and separately, HSP60 stabilizes mitochondrial survivin and restrains p53, with siRNA depletion activating caspase-dependent apoptosis in tumor cells.\",\n      \"evidence\": \"Exosome isolation with EM and pathway inhibitor studies; proteomics screening with Co-IP and siRNA knockdown\",\n      \"pmids\": [\"17307989\", \"18086682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals triggering exosomal HSP60 loading unknown\", \"Whether HSP60–p53 interaction is direct or chaperoning-dependent not distinguished\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Patient-derived cells carrying the SPG13-associated V98I mutation revealed a compensatory cellular adaptation: reduced HSP60 function led to decreased Lon and ClpP protease expression, suggesting cells modulate quality-control protease levels in response to impaired chaperoning.\",\n      \"evidence\": \"qRT-PCR and Western blot in lymphoblastoid and fibroblast lines from an SPG13 patient heterozygous for HSPD1 c.292G>A\",\n      \"pmids\": [\"18378094\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single patient study limits generalizability\", \"Causality between reduced HSP60 and protease downregulation not formally established\", \"Whether this compensation is neuroprotective or pathological unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The question of whether HSP60 is essential in mammals was definitively answered: homozygous Hspd1 knockout causes embryonic lethality at E6.5–7.5 in mice, while heterozygotes survive with reduced HSP60/HSP10 levels.\",\n      \"evidence\": \"Gene-trap knockout mouse with genotyping, qRT-PCR, and Western blot\",\n      \"pmids\": [\"20393889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific mitochondrial substrates fail to fold and cause lethality unknown\", \"Whether extra-mitochondrial HSP60 functions contribute to the lethal phenotype not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extracellular HSP60 was shown to function as a danger-associated molecular pattern (DAMP): it drives inflammatory cytokine production via TLR4–MyD88–p38/NF-κB signaling in cardiomyocytes, and MnSOD was identified as a specific mitochondrial folding substrate whose impairment under HSP60 haploinsufficiency increases neuronal oxidative stress.\",\n      \"evidence\": \"TLR blocking antibodies and pathway inhibitors with in vivo LAD ligation; Co-IP and enzymatic activity assays in heterozygous knockout mouse\",\n      \"pmids\": [\"23447644\", \"24151936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of HSP60–TLR4 recognition not determined\", \"Whether MnSOD misfolding is the primary driver of neurodegeneration in SPG13 not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A key structural distinction of mammalian HSP60 from bacterial GroEL was established: wild-type HSP60 exists as single heptameric rings in the apo state and transitions to double-ring football complexes with HSP10 only upon ATP binding, with ATP hydrolysis driving dissociation back to single rings.\",\n      \"evidence\": \"TEM, native PAGE, and gel filtration of purified porcine HSP60; complemented by native MS, DLS, and analytical ultracentrifugation\",\n      \"pmids\": [\"26427351\", \"29415503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether single-ring forms have independent folding activity unknown\", \"Physiological triggers controlling the single-to-double ring transition in vivo not identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Chemical biology approaches identified specific mitochondrial folding substrates: HSP60 inhibition by myrtucommulone A caused aggregation of LONP and LRP130, directly demonstrating their dependence on HSP60 for proper folding.\",\n      \"evidence\": \"Affinity pulldown with chemical probe; malate dehydrogenase refolding assay; 2D gel electrophoresis with MS identification of aggregated proteins in isolated mitochondria\",\n      \"pmids\": [\"28457707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Complete substrate repertoire of mammalian HSP60 remains undefined\", \"Whether substrate selectivity differs between single-ring and double-ring forms unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The physical mechanism by which the chaperonin cavity promotes folding was refined: encapsulation alone (without iterative cycling) repairs defined folding defects through equilibrium confinement-driven chain compaction, and GroEL rings undergo transient separation driven by inter-ring negative allostery that is required for efficient substrate processing in vivo.\",\n      \"evidence\": \"HX-MS of cavity-encapsulated MBP mutant; FRET-based ring exchange assays with engineered GroEL mutant plus in vivo growth complementation\",\n      \"pmids\": [\"29295923\", \"29336887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian HSP60 single-ring forms undergo analogous ring dynamics unknown\", \"Extent to which confinement versus active unfolding contributes under physiological substrate loads not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Disease mechanism was clarified at the structural level: cryo-EM of apo human HSP60 confirmed single-ring architecture with increased apical-domain flexibility relative to GroEL, and SPG13/leukodystrophy mutations D29G and V98I were shown to destabilize oligomeric integrity rather than monomer folding.\",\n      \"evidence\": \"Cryo-EM 3D reconstruction of human HSP60; biophysical characterization of purified mutant proteins with native gel and thermal stability assays\",\n      \"pmids\": [\"33506187\", \"32766281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of human HSP60–HSP10–ATP football complex not yet determined\", \"How oligomeric destabilization specifically affects neuronal vulnerability in SPG13 not mechanistically explained\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"HSP60's essentiality for mitochondrial oxidative phosphorylation and its druggability were demonstrated: HSPD1 knockout or pharmacological inhibition collapses OXPHOS and suppresses cancer cell proliferation, and arsenic trioxide directly binds HSP60, abolishing refolding activity and disrupting HSP60–p53 and HSP60–survivin complexes.\",\n      \"evidence\": \"CRISPR knockout plus KHS101 inhibition with Seahorse metabolic profiling and genome-wide CRISPR drug-sensitivity screen; organoarsenic chemical proteomics with cellular thermal shift assay\",\n      \"pmids\": [\"34364401\", \"34476069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Therapeutic window for HSP60 inhibition in cancer versus toxicity to normal tissues not defined\", \"Which OXPHOS complex subunits are direct HSP60 folding clients not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Single-molecule experiments revealed that GroEL/ES accelerates folding by actively strengthening polypeptide chain collapse via contractile forces drawing substrates into the cavity, a mechanism distinct from both passive steric confinement and iterative unfolding models.\",\n      \"evidence\": \"Integrated optical tweezers with single-molecule fluorescence imaging across defined nucleotide states\",\n      \"pmids\": [\"35245117\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian HSP60 exerts equivalent contractile forces on substrates not tested\", \"Structural basis of force generation at the apical domain not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions remain: the complete substrate repertoire of mammalian HSP60 in vivo, the atomic-resolution structure of the human HSP60–HSP10–ATP complex, the mechanistic basis of tissue-specific vulnerability (particularly neuronal) to HSP60 deficiency, and whether the single-ring-to-double-ring transition is regulated by signals beyond ATP availability.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No comprehensive substrate catalog for mammalian HSP60 exists\", \"High-resolution human HSP60–HSP10–substrate ternary complex structure not determined\", \"Cell-type-specific regulation of HSP60 ring dynamics not characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 4, 5, 7, 26, 32]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 4, 5, 20, 24]},\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2, 6, 8, 10, 15, 28]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 11, 27, 34]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [9, 14]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [34]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 4, 7, 21, 26, 32]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 10, 27, 34]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [15, 23]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [29, 33]}\n    ],\n    \"complexes\": [\n      \"HSP60–HSP10 chaperonin complex\",\n      \"HSP60–mortalin/mtHsp70 complex\",\n      \"HSP60–survivin–p53 mitochondrial complex\"\n    ],\n    \"partners\": [\n      \"HSPE1\",\n      \"HSPA9\",\n      \"TP53\",\n      \"BIRC5\",\n      \"CASP3\",\n      \"BAX\",\n      \"CTNNB1\",\n      \"YBX1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}